Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP6927259B2 - Adsorbents, columns, refiners and methods for manufacturing adsorbents - Google Patents
[go: Go Back, main page]

JP6927259B2 - Adsorbents, columns, refiners and methods for manufacturing adsorbents - Google Patents

Adsorbents, columns, refiners and methods for manufacturing adsorbents Download PDF

Info

Publication number
JP6927259B2
JP6927259B2 JP2019159875A JP2019159875A JP6927259B2 JP 6927259 B2 JP6927259 B2 JP 6927259B2 JP 2019159875 A JP2019159875 A JP 2019159875A JP 2019159875 A JP2019159875 A JP 2019159875A JP 6927259 B2 JP6927259 B2 JP 6927259B2
Authority
JP
Japan
Prior art keywords
carrier
stimulus
adsorbent
responsive polymer
evaluation value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2019159875A
Other languages
Japanese (ja)
Other versions
JP2021037459A (en
Inventor
七重 山下
七重 山下
優史 丸山
優史 丸山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Resonac Corp
Original Assignee
Hitachi Chemical Co Ltd
Showa Denko Materials Co Ltd
Resonac Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hitachi Chemical Co Ltd, Showa Denko Materials Co Ltd, Resonac Corp filed Critical Hitachi Chemical Co Ltd
Priority to JP2019159875A priority Critical patent/JP6927259B2/en
Publication of JP2021037459A publication Critical patent/JP2021037459A/en
Application granted granted Critical
Publication of JP6927259B2 publication Critical patent/JP6927259B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Description

本発明は、標的物質の精製に使用される吸着材、カラム、精製装置及び吸着材の製造方法に関する。 The present invention relates to an adsorbent, a column, a purification apparatus, and a method for producing an adsorbent used for purifying a target substance.

タンパク質や抗体のような生体分子を標的物質としたアフィニティ精製は、アフィニティ吸着材(以下、単に「吸着材」ということがある)への標的物質の吸着、非吸着成分の洗浄、溶離液による標的物質の吸着材からの回収を経て行われる。吸着材は、多糖類や樹脂、無機酸化物などからなる担体の表面上に、標的物質と相互作用を示す吸着部位を固定化することで構成されている。特に、抗体と特異的に吸着する低分子量の化合物(低分子化合物)を吸着部位として用いた吸着材は、プロテインAなどのタンパク質を用いた吸着材と比較して吸着材自身が低コストであること、及び化学薬品耐性が高く強アルカリ洗浄等の工程で吸着部位の劣化を低減できることから広く注目されている。 Affinity purification using biomolecules such as proteins and antibodies as target substances involves adsorbing the target substance to an affinity adsorbent (hereinafter, simply referred to as "adsorbent"), washing non-adsorbed components, and targeting with an eluent. It is carried out after the substance is recovered from the adsorbent. The adsorbent is composed of immobilizing an adsorbent site that interacts with a target substance on the surface of a carrier made of a polysaccharide, a resin, an inorganic oxide, or the like. In particular, an adsorbent using a low molecular weight compound (low molecular weight compound) that specifically adsorbs to an antibody as an adsorbent site has a lower cost than the adsorbent using a protein such as protein A. It is attracting widespread attention because it has high chemical resistance and can reduce the deterioration of the adsorption site in processes such as strong alkaline cleaning.

そのような吸着材が、例えば、特許文献1や非特許文献1〜3に記載されている。
具体的に、特許文献1には、免疫グロブリンを選択的に吸着するのに用いるシュドバイオアフィニティクロマトグラフィ吸着剤(吸着材に相当)であって、(a)固形支持材料、及び(b)この固形支持材料の表面に固定されたリガンド(吸着部位に相当)を含んでなり、前記リガンドが所定の化学構造のメルカプト五員複素環を有する化合物であることを特徴とするシュドバイオアフィニティクロマトグラフィ吸着剤が記載されている。
Such adsorbents are described, for example, in Patent Document 1 and Non-Patent Documents 1 to 3.
Specifically, Patent Document 1 describes a sud bioaffinity chromatography adsorbent (corresponding to an adsorbent) used for selectively adsorbing immunoglobulin, (a) a solid support material, and (b) this solid. A sud bioaffinity chromatography adsorbent comprising a ligand (corresponding to an adsorption site) immobilized on the surface of a support material, wherein the ligand is a compound having a mercapto five-membered heterocycle having a predetermined chemical structure. Have been described.

また、非特許文献1〜3には、吸着材にチオフィリック(thiophilic)なリガンドを用いたクロマトグラフィによる抗体精製などについて報告されている。 Further, Non-Patent Documents 1 to 3 report on antibody purification by chromatography using a thiophilic ligand as an adsorbent.

特表平10−500615号公報Special Table No. 10-500615

E. Boschetti et al., J. Biochem. Biophys. Methods, 2001, 49, pp.361-389.E. Boschetti et al., J. Biochem. Biophys. Methods, 2001, 49, pp.361-389. A. Schwarz et al., React. Polym., 1995, 22, pp.259-266.A. Schwarz et al., React. Polym., 1995, 22, pp.259-266. P. Kumplume et al., J. Chromato. A, 2004, 1022, pp.41-50.P. Kumplume et al., J. Chromato. A, 2004, 1022, pp.41-50.

しかしながら、特許文献1や非特許文献1〜3に記載されているような低分子化合物をリガンドとして用いる吸着材は、担体と低分子化合物とを繋ぐリンカー分子によって吸着材としての機能が大きく左右される。そのため、低分子化合物には、用いることのできる担体が限られているという問題がある。また、低分子化合物をリガンドとして用いる吸着材は、担体の界面性質によって大きな影響を受けるのでリガンドの配向制御が困難であり、抗体などの標的物質の吸着容量を高くするのが困難であるという問題がある。なお、本明細書において、担体の界面性質とは、親水性・疎水性などの表面性質をいう。 However, the function of an adsorbent using a small molecule compound as a ligand as described in Patent Document 1 and Non-Patent Documents 1 to 3 is greatly influenced by the linker molecule connecting the carrier and the small molecule compound. NS. Therefore, the small molecule compound has a problem that the carriers that can be used are limited. Further, an adsorbent using a small molecule compound as a ligand is greatly affected by the interfacial properties of the carrier, so that it is difficult to control the orientation of the ligand, and it is difficult to increase the adsorption capacity of a target substance such as an antibody. There is. In addition, in this specification, the interfacial property of a carrier means the surface property such as hydrophilicity and hydrophobicity.

本発明はこのような状況に鑑みてなされたものであり、吸着部位として低分子化合物を用いることができるとともに、従来よりも多くの種類の担体を用いることができ、かつ、標的物質の吸着容量が高い吸着材、カラム、精製装置及び吸着材の製造方法を提供することを課題とする。 The present invention has been made in view of such a situation, and a small molecule compound can be used as an adsorption site, more types of carriers can be used than before, and the adsorption capacity of the target substance can be used. It is an object of the present invention to provide an adsorbent, a column, a purification device, and a method for producing an adsorbent having a high content.

本発明者らは前記課題を解決するため鋭意研究開発したところ、1分子の高分子鎖に対する吸着部位(低分子化合物)の導入量を制御することで刺激応答性高分子全体の親水性・疎水性のバランスを制御しつつこれを所定の指標を満たす担体上へ固定化することによって標的物質の吸着容量を高くできることを見出し、本発明を完成するに至った。つまり、本発明は、刺激応答性高分子のある特定の条件範囲と、様々な界面性質を有する担体とを組み合わせることで、標的物質を含有する溶液から標的物質を極めて多く吸着することのできる吸着材を見出し、本発明を完成するに至ったものである。 The present inventors have diligently researched and developed to solve the above problems, and found that the hydrophilicity and hydrophobicity of the entire stimulus-responsive polymer are hydrophilic and hydrophobic by controlling the amount of the adsorption site (low molecular weight compound) introduced into one polymer chain. We have found that the adsorption capacity of the target substance can be increased by immobilizing this on a carrier that satisfies a predetermined index while controlling the sexual balance, and have completed the present invention. That is, the present invention is an adsorption capable of adsorbing an extremely large amount of a target substance from a solution containing the target substance by combining a specific condition range of a stimulus-responsive polymer with a carrier having various interfacial properties. The material was found and the present invention was completed.

前記課題を解決した本発明に係る吸着材は、担体と、標的物質を吸着する吸着部位及び前記吸着部位が導入されるアミノ基を含むとともに、前記担体に固定化された刺激応答性高分子と、を含む吸着材であり、前記担体は、誘電率の異なるオクタノール及びエタノールに分散させた際、それぞれの溶媒に対する前記担体の分散性を示す評価値から算出される指標Aが0以上1.0以下であり、前記刺激応答性高分子は、分配係数CLogPが−0.46以上1.3以下であり、前記指標Aは、前記オクタノール及び前記エタノールのそれぞれの溶媒に前記担体を分散させた分散液をシャーレに展開し、室温で10分静置した後、光学顕微鏡で撮像し得られた画像中の凝集体部分を黒色に、その他を白色に処理する二値化処理を行い、前記黒色で得られた凝集体部分の長さを1つの前記担体の直径で割った値をφとし、当該φの値に従って、評価値5:φ=0.2μm以上8.3μm未満、評価値4:φ=8.3μm以上17μm未満、評価値3:φ=17μm以上27μm未満、評価値2:φ=27μm以上40μm未満、評価値1:φ=40μm以上と評価し、これを1つのサンプルにつき5箇所の前記画像から得られた値の平均値を採用したものであり、さらに、これを1つのサンプルに対して2回繰り返して求めた平均値であって、前記オクタノールに分散させたときの評価値から、前記エタノールに分散させたときの評価値を差し引いた値を指標値とするものであり、前記担体は、合成樹脂で形成されており、前記吸着部位は、ベンゾチアゾール−2−酢酸、4−メルカプトベンゾチアゾール−2−酢酸エチル、5−メルカプトベンゾチアゾール−2−酢酸エチル、2−メルカプトチアゾール、3−(ベンゾチアゾール−2−イルチオ)プロパン−1−スルホン酸ナトリウム、2−メルカプト−6−ニトロベンゾチアゾール、3−(2−ベンゾチアゾリルチオ)プロピオン酸、2−メルカプト−1,3,4−チアジアゾール、N−メチル−2−メルカプトイミダゾール、ピリジルチオ酢酸、2−ベンゾチアゾリルチオ酢酸のうちから選択される少なくとも1種が、前記アミノ基にアミド結合したものであることとしている。なお、刺激応答性高分子とは、吸着部位を高分子鎖に導入した構造体をいう。 The adsorbent according to the present invention that solves the above-mentioned problems includes a carrier, an adsorption site for adsorbing a target substance, and an amino group into which the adsorption site is introduced , and a stimulus-responsive polymer immobilized on the carrier. When the carrier is dispersed in octanol and ethanol having different dielectric constants, the index A calculated from the evaluation value indicating the dispersibility of the carrier in each solvent is 0 or more and 1.0. or less, before Symbol stimuli-responsive polymer is partition coefficient CLogP is Ri der -0.46 to 1.3, the index a is to disperse the carrier to each of the solvent of the octanol and the ethanol The prepared dispersion was developed on a carrier and allowed to stand at room temperature for 10 minutes, and then subjected to a binarization treatment in which the aggregate portion in the image obtained by imaging with an optical microscope was treated to black and the others to white. The value obtained by dividing the length of the aggregate portion obtained in black by the diameter of one of the carriers is defined as φ, and the evaluation value 5: φ = 0.2 μm or more and less than 8.3 μm, the evaluation value 4 according to the value of φ. : Φ = 8.3 μm or more and less than 17 μm, evaluation value 3: φ = 17 μm or more and less than 27 μm, evaluation value 2: φ = 27 μm or more and less than 40 μm, evaluation value 1: φ = 40 μm or more, and this is evaluated per sample. The average value of the values obtained from the five images is adopted, and further, the average value obtained by repeating this twice for one sample when dispersed in the octanol. The index value is a value obtained by subtracting the evaluation value when dispersed in ethanol from the evaluation value, the carrier is formed of a synthetic resin, and the adsorption site is benzothiazole-2-acetic acid. , 4-Mercaptobenzothiazole-2-ethyl acetate, 5-Mercaptobenzothiazole-2-ethylacetate, 2-Mercaptothiazole, 3- (benzothiazole-2-ylthio) sodium propan-1-sulfonate, 2-mercapto- 6-Nitrobenzothiazole, 3- (2-benzothiazolylthio) propionic acid, 2-mercapto-1,3,4-thiasiazol, N-methyl-2-mercaptoimidazole, pyridylthioacetic acid, 2-benzothiazolylthioacetic acid It is assumed that at least one selected from the above is amide-bonded to the amino group. The stimulus-responsive polymer refers to a structure in which an adsorption site is introduced into a polymer chain.

本発明によれば、吸着部位として低分子化合物を用いることができるとともに、従来よりも多くの種類の担体を用いることができ、かつ、標的物質の吸着容量が高い吸着材、カラム、精製装置及び吸着材の製造方法を提供できる。
前記した以外の課題、構成及び効果は以下の実施形態の説明により明らかにされる。
According to the present invention, a small molecule compound can be used as an adsorption site, more types of carriers can be used than before, and an adsorbent, a column, a purification device and a purification device having a high adsorption capacity of a target substance can be used. A method for producing an adsorbent can be provided.
Issues, configurations and effects other than those described above will be clarified by the following description of the embodiments.

本実施形態に係る吸着材の構成を説明する概略図である。It is the schematic explaining the structure of the adsorbent which concerns on this embodiment. 本実施形態に係るカラムの構成を説明する概略図である。It is the schematic explaining the structure of the column which concerns on this embodiment. 本実施形態に係る精製装置の構成を説明する概略図である。It is the schematic explaining the structure of the purification apparatus which concerns on this embodiment. 実施例1〜9及び比較例1〜3に係る各吸着材における指標Aと10%DBCとの関係を示すグラフである。なお、横軸は指標Aを示し、縦軸は10%DBC(mg/mL)を示す。なお、DBCとは、動的吸着容量をいう。同図中、実施例を「■」でプロットし、比較例を「○」でプロットしている。It is a graph which shows the relationship between the index A and 10% DBC in each adsorbent which concerns on Examples 1-9 and Comparative Examples 1-3. The horizontal axis represents index A, and the vertical axis represents 10% DBC (mg / mL). The DBC refers to a dynamic adsorption capacity. In the figure, Examples are plotted with “■” and Comparative Examples are plotted with “○”.

以下、適宜図面を参照して本発明に係る吸着材、カラム、精製装置及び吸着材の製造方法の一実施形態について詳細に説明する。
なお、本明細書に記載される「〜」は、その前後に記載される数値を下限値及び上限値として有する意味で使用する。本明細書に段階的に記載されている数値範囲において、一つの数値範囲で記載された下限値又は上限値は、他の段階的に記載されている下限値又は上限値に置き換えてもよい。本明細書に記載される数値範囲の下限値又は上限値は、実施例中に示されている値に置き換えてもよい。
Hereinafter, an embodiment of an adsorbent, a column, a purification apparatus, and a method for producing an adsorbent according to the present invention will be described in detail with reference to the drawings as appropriate.
In addition, "~" described in this specification is used in the meaning of having numerical values described before and after it as a lower limit value and an upper limit value. In the numerical range described stepwise in the present specification, the lower limit value or the upper limit value described in one numerical range may be replaced with the lower limit value or the upper limit value described in another stepwise. The lower or upper limit of the numerical range described herein may be replaced with the values shown in the examples.

本明細書で説明している各要素は、各要素を構成する材料群の中から選択された材料を単独で又は複数組み合わせて使用してもよい。また、本明細書で説明している各要素や材料は、本明細書で記載した材料のみで構成されていてもよく、本発明の効果を損なわない範囲で本明細書に記載していない他の材料を有していてもよい。 For each element described in the present specification, a material selected from the material group constituting each element may be used alone or in combination of two or more. In addition, each element or material described in the present specification may be composed only of the material described in the present specification, and is not described in the present specification to the extent that the effect of the present invention is not impaired. You may have the material of.

<吸着材1>
図1は、本実施形態に係る吸着材1の構成を説明する概略図である。
図1に示すように、吸着材1は、担体2と、標的物質Oを吸着する吸着部位3を含むとともに、前記担体2に固定化された刺激応答性高分子4と、を含んでいる。刺激応答性高分子4は、高分子鎖5を備えており、当該高分子鎖5に吸着部位3を複数導入するとともに、刺激応答性高分子4全体の親水性・疎水性のバランスを制御する官能基Rが導入されている。
<Adsorbent 1>
FIG. 1 is a schematic view illustrating the configuration of the adsorbent 1 according to the present embodiment.
As shown in FIG. 1, the adsorbent 1 includes a carrier 2 and an adsorption site 3 that adsorbs the target substance O, and also contains a stimulus-responsive polymer 4 immobilized on the carrier 2. The stimulus-responsive polymer 4 includes a polymer chain 5, and a plurality of adsorption sites 3 are introduced into the polymer chain 5 and the balance between hydrophilicity and hydrophobicity of the entire stimulus-responsive polymer 4 is controlled. The functional group R has been introduced.

標的物質Oとしては、例えば、生理活性物質や工業的に有用なタンパク質などが挙げられる。生理活性物質としては、特に、抗体(抗体分子・抗体タンパク質)が挙げられる。本実施形態における抗体とは、ガンマグロブリン及び免疫グロブリンのことをいうが、特に、医薬品としてヒトに対して投与可能なもの、又は分析試薬に導入するようなヒトに対して投与しないもののいずれも含まれる。医薬品として適用できる抗体は、クラスやサブクラスに限定されない。例えば、定常領域の構造が異なるIgG、IgM、IgA、IgD、IgEの5種類が挙げられるが、各免疫グロブリンのいずれであってもよい。ヒト抗体においては、IgG1〜IgG4の4つのサブクラスがあり、またIgAにおいてもIgA1、IgA2と2つのサブクラスがあるが本実施形態では特に限定されない。さらに、抗体は、由来や製造方法によっても分類することができ、天然のヒト抗体や遺伝子組み換え技術により生産された組み換えヒト抗体、あるいはモノクローナル抗体やポリクローナル抗体のいずれであってもよい。特にこれらの抗体の中でも、医薬品原料として重要性が最も大きいヒトIgGへの適用が有意義である。また、抗体は、ヒト化抗体、ヒトIgGとのキメラなどであってもよい。なお、ヒト化抗体とは可変領域のうち、相補性決定領域がヒト以外の生物由来で、その他のフレームワーク領域をヒト由来にしたものをいう。ヒトIgGとのキメラとは、可変領域はマウスなどのヒト以外の生物由来であるが、その他の定常領域をヒト由来の免疫グロブリンに置換したものをいう。なお、生理活性物質は抗体に限定されるものではなく、生物に対して生理作用や薬理作用を発現する物質単体及び化合物群であればどのようなものも含まれる。生物に対して生理作用や薬理作用を発現する物質単体及び化合物群としては、例えば、アルカロイド、サイトカイン、植物ホルモン、神経伝達物質、フェロモン、ホルモン(動物のホルモン)などのほか、成長因子、成長調節因子、成長阻害因子などが挙げられる。生物に対して生理作用や薬理作用を発現する物質単体及び化合物群の一例として、例えば、血栓溶解剤として利用される組織型プラスミノーゲン活性化因子やインスリンなどのバイオ医薬品が挙げられる。また、工業的に有用なタンパク質としては、例えば、酸化還元酵素、転移酵素、加水分解酵素、除去付加酵素、異性化酵素、合成酵素などが挙げられる。さらに、標的物質Oとしては、例えば、β−カロテンやアスタキサンチンなどのカロチノイド、クロロフィルやバクテリオクロロフィルなどの色素、食品又は化粧品などの着色などに使用されるフィコシアニンなどのフィコビリンタンパク質、脂肪酸などの生理活性物質が挙げられる。 Examples of the target substance O include physiologically active substances and industrially useful proteins. Examples of the physiologically active substance include antibodies (antibody molecules / antibody proteins). The antibody in the present embodiment refers to gamma globulin and immunoglobulin, and in particular, includes either an antibody that can be administered to humans as a pharmaceutical product or an antibody that is not administered to humans as introduced into an analytical reagent. Is done. Antibodies applicable as pharmaceuticals are not limited to classes or subclasses. For example, there are five types of IgG, IgM, IgA, IgD, and IgE having different constant region structures, and any of the immunoglobulins may be used. Human antibodies have four subclasses of IgG1 to IgG4, and IgA also has two subclasses of IgA1 and IgA2, but the present embodiment is not particularly limited. Further, the antibody can be classified according to the origin and the production method, and may be either a natural human antibody, a recombinant human antibody produced by a gene recombination technique, or a monoclonal antibody or a polyclonal antibody. In particular, among these antibodies, application to human IgG, which is the most important as a pharmaceutical raw material, is meaningful. Further, the antibody may be a humanized antibody, a chimera with human IgG, or the like. The humanized antibody refers to a variable region in which the complementarity determining region is derived from an organism other than human and the other framework regions are derived from human. The chimera with human IgG means that the variable region is derived from a non-human organism such as a mouse, but the other constant region is replaced with a human-derived immunoglobulin. The bioactive substance is not limited to the antibody, and includes any substance alone or a group of compounds that exerts a physiological action or a pharmacological action on an organism. Examples of substances and compound groups that exert physiological and pharmacological actions on living organisms include alkaloids, cytokines, plant hormones, neurotransmitters, pheromones, hormones (animal hormones), growth factors, and growth regulators. Factors, growth inhibitory factors and the like can be mentioned. Examples of simple substances and compound groups that exert physiological and pharmacological actions on living organisms include biopharmacy such as tissue plasminogen activator and insulin used as thrombolytic agents. Examples of industrially useful proteins include oxidoreductases, transferases, hydrolases, depleting and adding enzymes, isomerases, and synthases. Further, the target substance O includes, for example, carotenoids such as β-carotene and astaxanthin, pigments such as chlorophyll and bacteriochlorophyll, phycobilin proteins such as phycocyanin used for coloring foods or cosmetics, and physiologically active substances such as fatty acids. Can be mentioned.

医薬品などの抗体は、例えば、原料となる抗体を細胞培養によって産生する産生工程、培養時に含まれる複数の夾雑物の中から抗体を選択的に回収し純度を高める精製工程、そしてウイルスを除去するウイルス除去工程、ウイルスを除去した抗体を含む溶液を濃縮したり、緩衝液を交換したりする濃縮・液交換工程、適宜の薬剤形態に製剤する製剤化工程などを経て製造される。前記フローは一般的な工程として知られているものであり、これに限定されない。 For antibodies such as pharmaceuticals, for example, a production step of producing an antibody as a raw material by cell culture, a purification step of selectively recovering the antibody from a plurality of impurities contained in the culture to increase the purity, and removing the virus. It is produced through a virus removal step, a concentration / liquid exchange step of concentrating a solution containing a virus-removed antibody, exchanging a buffer solution, a formulation step of formulating into an appropriate drug form, and the like. The flow is known as a general process and is not limited thereto.

前記工程の中で、本実施形態に係る吸着材1は特に精製工程で用いられる。吸着材1の役割は、溶液中に含まれている抗体と夾雑物とを分けて抗体を精製して回収することにある。精製工程の一例として、アフィニティクロマトグラフィを用いた初期精製、その後イオン交換体を用いた中期、後期精製工程などがあるが、これらに限定されるものではない。なお、以下の説明において、本実施形態に係る吸着材1を用いる精製工程(初期工程)に投入する直前の溶液を抗体含有溶液ということがある。 In the above steps, the adsorbent 1 according to the present embodiment is particularly used in the purification step. The role of the adsorbent 1 is to separate the antibody and impurities contained in the solution and purify and recover the antibody. Examples of the purification step include, but are not limited to, initial purification using affinity chromatography, and then medium-term and late-stage purification steps using an ion exchanger. In the following description, the solution immediately before being put into the purification step (initial step) using the adsorbent 1 according to the present embodiment may be referred to as an antibody-containing solution.

吸着材1について説明を続ける。
担体2は、多孔質及び非多孔質のいずれであってもよい。担体2の態様としては、例えば、板状、ビーズ(粒子)状、不織布や織物などの繊維状、膜状、モノリス状、中空糸状などが挙げられる。また、担体2は、コアシェル構造のものであってもよい。
The description of the adsorbent 1 will be continued.
The carrier 2 may be either porous or non-porous. Examples of the mode of the carrier 2 include a plate shape, a bead (particle) shape, a fibrous shape such as a non-woven fabric or a woven fabric, a film shape, a monolith shape, a hollow thread shape, and the like. Further, the carrier 2 may have a core-shell structure.

担体2は、例えば、多糖類、合成樹脂、無機化合物及びそれらの複合材料を含む材料で形成されたものであってよい。多糖類は、架橋された多糖類であってもよい。多糖類又は架橋された多糖類としては、例えば、アガロース、架橋アガロース、疎水化アガロース、セルロースなどが挙げられる。合成樹脂としては、例えば、アクリル樹脂(例えば、ポリアルキルアクリレート、ポリアルキルメタクリレート、ポリグリシジルアクリレート、ポリグリシジルメタクリレートなど)、ポリスチレン、ポリビニルアルコール、ポリビニルピロリドン、ポリアクリルアミド、ポリシロキサン、ポリフッ化エチレンなどが挙げられる。無機化合物としては、例えば、シリカ、金属酸化物(例えば、アルミナ、チタニア、ジルコニア、酸化鉄など)、フェライト、ハイドロキシアパタイト、シリケートなどが挙げられる。担体2は、多糖類、架橋された多糖類、合成樹脂、シリカ又は金属酸化物を有することが好ましく、多糖類又は架橋された多糖類を有することがより好ましい。なお、担体2は、これらの材料を少なくとも担体2の表面に有していればよい。すなわち、担体2の表面が、多糖類、架橋された多糖類、合成樹脂、シリカ又は金属酸化物、好ましくは多糖類又は架橋された多糖類を有するコアシェル構造のものであってもよい。よって、担体2又は担体2の表面が、多糖類、架橋された多糖類、合成樹脂、シリカ又は金属酸化物を有するものが好ましく、多糖類又は架橋された多糖類を有するものがより好ましい。 The carrier 2 may be formed of, for example, a material containing a polysaccharide, a synthetic resin, an inorganic compound, and a composite material thereof. The polysaccharide may be a crosslinked polysaccharide. Examples of the polysaccharide or the crosslinked polysaccharide include agarose, crosslinked agarose, hydrophobized agarose, cellulose and the like. Examples of the synthetic resin include acrylic resins (for example, polyalkyl acrylate, polyalkyl methacrylate, polyglycidyl acrylate, polyglycidyl methacrylate, etc.), polystyrene, polyvinyl alcohol, polyvinylpyrrolidone, polyacrylamide, polysiloxane, polyfluorinated ethylene, and the like. Be done. Examples of the inorganic compound include silica, metal oxides (for example, alumina, titania, zirconia, iron oxide, etc.), ferrite, hydroxyapatite, silicate and the like. The carrier 2 preferably has a polysaccharide, a crosslinked polysaccharide, a synthetic resin, silica or a metal oxide, and more preferably has a polysaccharide or a crosslinked polysaccharide. The carrier 2 may have these materials at least on the surface of the carrier 2. That is, the surface of the carrier 2 may have a core-shell structure having a polysaccharide, a crosslinked polysaccharide, a synthetic resin, silica or a metal oxide, preferably a polysaccharide or a crosslinked polysaccharide. Therefore, it is preferable that the surface of the carrier 2 or the carrier 2 has a polysaccharide, a crosslinked polysaccharide, a synthetic resin, silica or a metal oxide, and more preferably a polysaccharide or a crosslinked polysaccharide.

また、担体2の表面は、カルボキシル基、アミノ基、水酸基、エポキシ基、エステル基などの反応性基によって修飾されていてもよい。刺激応答性高分子4をより多く導入できるという観点、すなわち吸着部位3をより多く導入できるという観点から、担体2の表面はカルボキシル基によって修飾されていることが好ましい。 Further, the surface of the carrier 2 may be modified with a reactive group such as a carboxyl group, an amino group, a hydroxyl group, an epoxy group or an ester group. The surface of the carrier 2 is preferably modified with a carboxyl group from the viewpoint that a larger amount of the stimulus-responsive polymer 4 can be introduced, that is, a larger amount of the adsorption site 3 can be introduced.

担体2の平均粒子径は、3μm以上100μm以下であることが好ましい。このようにすると、担体2の表面積が十分得られるので、動的吸着容量(DBC)がより増大化する。なお、DBCとは、標的物質Oが流れている状態で、標的物質Oがどれだけ吸着材1に吸着されるか(吸着材1の結合容量)を表す指標をいい、単位体積当たりの吸着量(例えば、「mg/mL」)で表すことができる。 The average particle size of the carrier 2 is preferably 3 μm or more and 100 μm or less. In this way, the surface area of the carrier 2 is sufficiently obtained, so that the dynamic adsorption capacity (DBC) is further increased. The DBC is an index showing how much the target substance O is adsorbed on the adsorbent 1 (bonding capacity of the adsorbent 1) while the target substance O is flowing, and the amount of adsorption per unit volume. It can be expressed as (for example, "mg / mL").

平均粒子径は、例えば、JIS Z 8815に準拠した手法で測定できる。また、平均粒子径は、例えば、振動式ふるい分け装置やレーザー回折式粒度分布測定装置、光子相関法式粒度分布測定装置で測定できる。担体が、例えば、ポリスチレンの場合は振動式ふるい分け装置で測定でき、Sepharose(登録商標)の場合はレーザー回折式粒度分布測定で測定でき、磁性微粒子の場合は光子相関法式粒度分布測定装置で測定できる。さらに、平均粒子径が40μm〜数mmであるものは振動式ふるい分け装置で測定でき、100〜1000μmであるものはレーザー回折式粒度分布測定装置で測定できる。 The average particle size can be measured, for example, by a method according to JIS Z 8815. Further, the average particle size can be measured by, for example, a vibration type sieving device, a laser diffraction type particle size distribution measuring device, or a photon correlation method particle size distribution measuring device. For example, when the carrier is polystyrene, it can be measured by a vibration type sieving device, when it is Sepharose (registered trademark), it can be measured by a laser diffraction type particle size distribution measurement, and when it is a magnetic fine particle, it can be measured by a photon correlation method particle size distribution measuring device. .. Further, those having an average particle size of 40 μm to several mm can be measured by a vibrating sieving device, and those having an average particle size of 100 to 1000 μm can be measured by a laser diffraction type particle size distribution measuring device.

本実施形態における吸着部位3は、低分子化合物に由来する部位である。吸着部位3は、例えば、標的物質Oが抗体であって、これを精製するカラムがアフィニティカラムであるときにおけるリガンドに相当する。 The adsorption site 3 in the present embodiment is a site derived from a small molecule compound. The adsorption site 3 corresponds to, for example, a ligand when the target substance O is an antibody and the column for purifying the antibody is an affinity column.

吸着部位3は、例えば、アミド結合などの任意の化学結合を介して高分子鎖5の側鎖に導入されている。吸着部位3を導入するために用いられる化合物は、高分子鎖5の官能基R(例えば、アミノ基など)と結合可能な部分を有するものであれば特に限定されない。このような化合物としては、例えば、アミド結合を形成するためのカルボキシル基、アズラクトン基、イミダゾール基、シアノエステル基、エポキシ基、アセチル基、アセトキシ基、アクリロイル基、アルコキシ基を有する化合物が挙げられる。また、このような化合物としては、例えば、カルボン酸無水物、カルボン酸ハロゲン化物、尿素結合を形成するためのイソシアネート基を有する化合物、チオ尿素結合を形成するためのイソチオシアネート基を有する化合物、スルホンアミド結合を形成するための塩化スルホニル基を有する化合物、アミドエステル結合を形成するためのオキサゾリン基を有する化合物などが挙げられる。 The adsorption site 3 is introduced into the side chain of the polymer chain 5 via an arbitrary chemical bond such as an amide bond. The compound used for introducing the adsorption site 3 is not particularly limited as long as it has a portion capable of binding to the functional group R (for example, an amino group) of the polymer chain 5. Examples of such a compound include a compound having a carboxyl group, an azlactone group, an imidazole group, a cyano ester group, an epoxy group, an acetyl group, an acetoxy group, an acryloyl group, and an alkoxy group for forming an amide bond. Examples of such a compound include a carboxylic acid anhydride, a carboxylic acid halide, a compound having an isocyanate group for forming a urea bond, a compound having an isothiocyanate group for forming a thiourea bond, and a sulfone. Examples thereof include a compound having a sulfonyl chloride group for forming an amide bond, a compound having an oxazoline group for forming an amide ester bond, and the like.

吸着部位3を導入するために用いられる化合物として、具体的には、メルカプトイミダゾール、メルカプトベンゾチアゾール、メルカプトテトラゾール、メルカプトチアジアゾールなどが挙げられる。より具体的には、ベンゾチアゾール−2−酢酸、4−メルカプトベンゾチアゾール−2−酢酸エチル、5−メルカプトベンゾチアゾール−2−酢酸エチル、2−メルカプトチアゾール、3−(ベンゾチアゾール−2−イルチオ)プロパン−1−スルホン酸ナトリウム、2−メルカプト−6−ニトロベンゾチアゾール、3−(2−ベンゾチアゾリルチオ)プロピオン酸、2−メルカプト−1,3,4−チアジアゾール、N−メチル−2−メルカプトイミダゾール、ピリジルチオ酢酸(例えば、2−ピリジルチオ酢酸、4−ピリジルチオ酢酸)、2−ベンゾチアゾリルチオ酢酸などが挙げられる。 Specific examples of the compound used for introducing the adsorption site 3 include mercaptoimidazole, mercaptobenzothiazole, mercaptotetrazole, and mercaptothiadiazole. More specifically, benzothiazole-2-acetic acid, 4-mercaptobenzothiazole-2-ethyl acetate, 5-mercaptobenzothiazole-2-ethylacetate, 2-mercaptothiazole, 3- (benzothiazole-2-ylthio) Sodium propan-1-sulfonate, 2-mercapto-6-nitrobenzothiazole, 3- (2-benzothiazolylthio) propionic acid, 2-mercapto-1,3,4-thiazylazole, N-methyl-2-mercapto Examples thereof include imidazole, pyridylthioacetic acid (for example, 2-pyridylthioacetic acid, 4-pyridylthioacetic acid), 2-benzothiazolylthioacetic acid and the like.

刺激応答性高分子4における吸着部位3の導入量は、複数のアミノ基などの官能基Rを有する高分子鎖5中に含まれる官能基数に対して5%以上であれば十分であり、最大95%程度導入できる。なお、吸着材1の高い抗体吸着特性の観点から、好ましくは7%以上である。単量体を重合させて高分子鎖5を形成する場合、単量体が有している吸着部位3を導入可能な官能基Rを把握しておけば、高分子鎖5中の官能基数も容易に把握することができる。従って、例えば、1分子の高分子鎖5が、吸着部位3を導入可能な官能基Rを30個有している場合、吸着部位3の導入量は、そのうちの5%〜95%(官能基数1.5個〜28.5個)とすることができる。すなわち、本実施形態において、刺激応答性高分子4は、吸着部位3を複数個有するとともに官能基Rを複数個有していることが好ましい。このようにすると、刺激応答性高分子4全体の親水性・疎水性のバランスがより制御し易くなり、DBCをより増大化することができる。 The amount of the adsorption site 3 introduced in the stimulus-responsive polymer 4 is sufficient if it is 5% or more of the number of functional groups contained in the polymer chain 5 having a functional group R such as a plurality of amino groups, and is maximum. About 95% can be introduced. From the viewpoint of the high antibody adsorption characteristics of the adsorbent 1, it is preferably 7% or more. When the monomer is polymerized to form the polymer chain 5, if the functional group R into which the adsorption site 3 of the monomer can be introduced is known, the number of functional groups in the polymer chain 5 can also be increased. It can be easily grasped. Therefore, for example, when one molecule of the polymer chain 5 has 30 functional groups R into which the adsorption site 3 can be introduced, the amount of the adsorption site 3 introduced is 5% to 95% (the number of functional groups). 1.5 to 28.5). That is, in the present embodiment, it is preferable that the stimulus-responsive polymer 4 has a plurality of adsorption sites 3 and a plurality of functional groups R. In this way, the balance between hydrophilicity and hydrophobicity of the entire stimulus-responsive polymer 4 can be more easily controlled, and the DBC can be further increased.

本実施形態において、吸着材1における吸着部位3の導入量は、H−NMRで1分子あたりの刺激応答性高分子4内に導入された吸着部位3の導入率を求め、その後、担体2上に固定化した刺激応答性高分子4の量を同定することによって求められる。すなわち、吸着材1における吸着部位3の導入量は、担体2上に固定化した刺激応答性高分子4について、1分子当たりの吸着部位導入率(量)と1mLの担体2上に固定化された刺激応答性高分子4の量との積によって求められる。 In the present embodiment, the amount of the adsorbed site 3 introduced into the adsorbent 1 is determined by 1 H-NMR for determining the introduction rate of the adsorbed site 3 introduced into the stimulus-responsive polymer 4 per molecule, and then the carrier 2 It is determined by identifying the amount of stimulus-responsive polymer 4 immobilized on top. That is, the introduction amount of the adsorption site 3 in the adsorbent 1 is the adsorption site introduction rate (amount) per molecule and the adsorption amount of the stimulus-responsive polymer 4 immobilized on the carrier 2 on the carrier 2. It is determined by the product of the amount of the stimulus-responsive polymer 4.

担体2上に固定化した刺激応答性高分子4の量の同定は次のようにして行う。まず、担体2に縮合剤と刺激応答性高分子4を溶解させた溶液を接触させ、固定化反応を行う。その後、溶媒で複数回洗浄し、回収してきた上澄み溶液中の吸着部位3を含む溶液を高速液体クロマトグラフィで分析する。仕込時の刺激応答性高分子4から、洗浄時に溶出した吸着部位3の量を差し引くことで担体2上に固定化された刺激応答性高分子4の量を見積もることができる。 The amount of the stimulus-responsive polymer 4 immobilized on the carrier 2 is identified as follows. First, a solution in which a condensing agent and a stimulus-responsive polymer 4 are dissolved is brought into contact with the carrier 2 to carry out an immobilization reaction. Then, the solution is washed with a solvent a plurality of times, and the solution containing the adsorption site 3 in the recovered supernatant solution is analyzed by high-speed liquid chromatography. The amount of the stimulus-responsive polymer 4 immobilized on the carrier 2 can be estimated by subtracting the amount of the adsorption site 3 eluted during washing from the stimulus-responsive polymer 4 at the time of charging.

また、刺激応答性高分子4は、複数の官能基Rを有する高分子鎖5と、吸着部位3を導入するための化合物を、高分子鎖5:吸着部位3を導入するための化合物が、1:0.01〜10のモル比で、好ましくは1:0.1〜5のモル比で、より好ましくは1:0.1〜2のモル比で反応させることで得られる。 Further, the stimulus-responsive polymer 4 includes a polymer chain 5 having a plurality of functional groups R and a compound for introducing the adsorption site 3, and a polymer chain 5: a compound for introducing the adsorption site 3. It is obtained by reacting with a molar ratio of 1: 0.01 to 10, preferably a molar ratio of 1: 0.1 to 5, and more preferably a molar ratio of 1: 0.1 to 2.

官能基Rは、任意の水溶液中や緩衝液中で正の電荷を帯びるもの又は負の電荷を帯びるものを適宜選択して用いることができる。官能基Rが帯びる電荷の価数は1〜3であればよい。つまり、このような官能基Rを備える刺激応答性高分子4は、イオン性高分子であるため、強酸などを用いることなく標的物質Oの回収が可能である。 As the functional group R, one having a positive charge or one having a negative charge in an arbitrary aqueous solution or a buffer solution can be appropriately selected and used. The valence of the electric charge carried by the functional group R may be 1 to 3. That is, since the stimulus-responsive polymer 4 having such a functional group R is an ionic polymer, the target substance O can be recovered without using a strong acid or the like.

官能基Rは、刺激応答性高分子4全体の親水性・疎水性のバランスを制御できればよく、特に限定されない。従って、官能基Rとしては、例えば、アミノ基、イミノ基、各種含窒素芳香族基(ピロール基、イミダゾリル基、ピリジル基、ピリミジル基、オキサゾリル基、チアゾリル基及びトリアゾリル基等)、グアニジル基、フェノール性水酸基、ヒドロキシ基、アルデヒド基、カルボニル基、カルボキシル基、アゾ基、ニトロ基、ニトロソ基、チオール基、スルホ基、エーテル基、ボロン酸基、フルオロ基、クロロ基、ブロモ基、ヨード基、ホスホリル基、ホスフィニル基、シリケート基、リン酸基及びそれらの誘導体の基などを挙げることができる。官能基Rは、これらのうちの1種類のみを用いてもよいし、複数種を組み合わせて用いてもよい。なお、官能基Rとしては、これらの中でもアミノ基を好適に用いることができる。すなわち、高分子鎖5はアミノ基を複数有するポリアミンを好適に用いることができる。 The functional group R is not particularly limited as long as it can control the hydrophilicity / hydrophobic balance of the entire stimulus-responsive polymer 4. Therefore, the functional group R includes, for example, an amino group, an imino group, various nitrogen-containing aromatic groups (pyrrole group, imidazolyl group, pyridyl group, pyrimidyl group, oxazolyl group, thiazolyl group, triazolyl group, etc.), guanidyl group, phenol. Sexual hydroxyl group, hydroxy group, aldehyde group, carbonyl group, carboxyl group, azo group, nitro group, nitroso group, thiol group, sulfo group, ether group, boronic acid group, fluoro group, chloro group, bromo group, iodo group, phosphoryl Examples thereof include a group, a phosphinyl group, a silicate group, a phosphate group and a group of a derivative thereof. As the functional group R, only one of these may be used, or a plurality of types may be used in combination. As the functional group R, an amino group can be preferably used among these. That is, a polyamine having a plurality of amino groups can be preferably used for the polymer chain 5.

また、官能基Rは、標的物質Oと水素結合を形成できるものであってもよい。このようにすると、標的物質Oの選択性を向上できるため、高い分離能が得られる。そのような官能基Rとしては、例えば、スルホ基、カルボキシル基、水酸基、アミノ基などが挙げられる。 Further, the functional group R may be one capable of forming a hydrogen bond with the target substance O. In this way, the selectivity of the target substance O can be improved, so that a high separation ability can be obtained. Examples of such a functional group R include a sulfo group, a carboxyl group, a hydroxyl group, an amino group and the like.

高分子鎖5は、デンドリマーであってもよい。高分子鎖5としては、例えば、ポリリジン(α−ポリリジン、ε−ポリリジン)、ポリエチレンイミン(直鎖ポリエチレンイミン、分岐ポリエチレンイミン)、ポリアリルアミン、ポリビニルアミン並びにそれらを部分構造として有する誘導体及び共重合体などが挙げられるが、ε−ポリリジン、ポリエチレンイミン、ポリアリルアミン又はそれらを部分構造として含むものが好ましく、より多くの吸着部位3を導入できるという観点から、ε−ポリリジンがより好ましい。 The polymer chain 5 may be a dendrimer. Examples of the polymer chain 5 include polylysine (α-polylysine, ε-polylysine), polyethyleneimine (linear polyethyleneimine, branched polyethyleneimine), polyallylamine, polyvinylamine, and derivatives and copolymers having them as a partial structure. However, ε-polylysine, polyethyleneimine, polyallysine or those containing them as a partial structure are preferable, and ε-polylysine is more preferable from the viewpoint that more adsorption sites 3 can be introduced.

高分子鎖5の重量平均分子量は1000〜100000であることが好ましく、1000〜6000であることがより好ましい。本実施形態における高分子鎖5の重量平均分子量は、ゲル浸透クロマトグラフィによって測定したものをいう。 The weight average molecular weight of the polymer chain 5 is preferably 1000 to 100,000, more preferably 1000 to 6000. The weight average molecular weight of the polymer chain 5 in the present embodiment means that measured by gel permeation chromatography.

高分子鎖5と吸着部位3の組合せとしては、吸着材1の高い標的物質吸着特性の観点から、ε−ポリリジン、ポリエチレンイミン又はポリアリルアミンと前記した吸着部位3との各組合せが好ましい。 As the combination of the polymer chain 5 and the adsorption site 3, each combination of ε-polylysine, polyethyleneimine or polyallylamine and the above-mentioned adsorption site 3 is preferable from the viewpoint of the high target substance adsorption characteristics of the adsorbent 1.

高分子鎖5への吸着部位3の導入は、高分子鎖5を担体2に固定化する前及び後のいずれで行ってもよい。すなわち、吸着部位3を高分子鎖5に導入し、その後、吸着部位3が導入された高分子鎖5を担体2に固定化してもよく、吸着部位3を有さない高分子鎖5を担体2に固定化した後に、固定化した高分子鎖5に吸着部位3を導入してもよい。 The adsorption site 3 may be introduced into the polymer chain 5 either before or after immobilizing the polymer chain 5 on the carrier 2. That is, the adsorption site 3 may be introduced into the polymer chain 5, and then the polymer chain 5 into which the adsorption site 3 has been introduced may be immobilized on the carrier 2, and the polymer chain 5 having no adsorption site 3 may be used as the carrier. After immobilization to 2, the adsorption site 3 may be introduced into the immobilized polymer chain 5.

次に、DBCの増大化が認められる刺激応答性高分子4の分配係数CLogPの条件について述べる。なお、本実施形態において分配係数CLogPとは、LogPの予測値の一つであり、コンピュータで計算することができる。分配係数CLogPは、これを計算できる機能を有するソフトウェアを使用することによって算出できる。そのようなソフトウェアとしては、化学構造式作画ソフトウェアが挙げられる。そして、そのような化学構造式作画ソフトウェアとして、例えば、ChemDrawが挙げられる。また、前記したLogPとは、化合物の疎水性、脂溶性を規定する無次元数の指標をいう。LogPは実験値であり、例えば、n−オクタノールと水を用いた分配係数を用いることができる。 Next, the conditions of the partition coefficient CLogP of the stimulus-responsive polymer 4 in which the increase in DBC is observed will be described. In the present embodiment, the partition coefficient CLogP is one of the predicted values of LogP and can be calculated by a computer. The partition coefficient CRogP can be calculated by using software having a function capable of calculating this. Examples of such software include chemical structural formula drawing software. And, as such chemical structural formula drawing software, ChemDraw is mentioned, for example. Further, the LogP described above refers to an index of a dimensionless number that defines the hydrophobicity and lipophilicity of the compound. LogP is an experimental value, and for example, a partition coefficient using n-octanol and water can be used.

本実施形態では前記したように、低分子化合物を吸着部位3とする刺激応答性高分子4を用いる。そして、本実施形態ではそのような刺激応答性高分子4を用いてDBCを増大させるため、刺激応答性高分子4の疎水度合いを示す分配係数CLogPが−0.46以上1.3以下であることを要する。このようにすると、分配係数CLogPがこの数値範囲内にある刺激応答性高分子4を担体2に固定化する際、後記する指標Aを満たす種々の担体2に対してより最適な刺激応答性高分子4との組み合わせを行うことができ、DBCが大幅に向上する。 In the present embodiment, as described above, the stimulus-responsive polymer 4 having the small molecule compound as the adsorption site 3 is used. In this embodiment, since the DBC is increased by using such a stimulus-responsive polymer 4, the partition coefficient CLogP indicating the degree of hydrophobicity of the stimulus-responsive polymer 4 is −0.46 or more and 1.3 or less. It takes that. In this way, when the stimulus-responsive polymer 4 having the partition coefficient CLogP within this numerical range is immobilized on the carrier 2, the stimulus-responsive polymer 4 satisfying the index A described later is more optimally high in stimulus responsiveness. The combination with the molecule 4 can be performed, and the DBC is greatly improved.

本実施形態における刺激応答性高分子4の分配係数CLogPは、高分子鎖5と吸着部位3の化学構造式からそれぞれの分配係数CLogPを求め、1分子の高分子鎖5当たりの吸着部位導入量を変化させ、平均値を刺激応答性高分子4の分配係数CLogPとするとよい。なお、分配係数CLogPの値が大きいほど、刺激応答性高分子4がより疎水的な性質を示し、分配係数CLogPが小さいほど、より親水的な性質を示す。 For the partition coefficient CLogP of the stimulus-responsive polymer 4 in the present embodiment, the respective partition coefficients CLogP are obtained from the chemical structural formulas of the polymer chain 5 and the adsorption site 3, and the amount of the adsorption site introduced per molecule of the polymer chain 5 is obtained. Is changed, and the average value is defined as the partition coefficient CLogP of the stimulus-responsive polymer 4. The larger the value of the partition coefficient CLogP, the more hydrophobic the stimulus-responsive polymer 4 shows, and the smaller the partition coefficient CRogP, the more hydrophilic the property.

次に、DBCの増大化が認められる担体2の条件について述べる。本実施形態では、低分子化合物を吸着部位3とする刺激応答性高分子4を用いる。そして、本実施形態ではそのような刺激応答性高分子4を用いてDBCを増大させるため、担体2の溶媒に対する分散性を示す後記する指標Aが1.0以下であることを要する。このように、指標Aが1.0以下である担体2と、前記した分配係数CLogPが−0.46以上1.3以下である刺激応答性高分子4との組み合わせによりDBCが大幅に向上する。下記に、指標Aの算出方法を具体的に記載する。 Next, the conditions for the carrier 2 in which the increase in DBC is observed will be described. In this embodiment, a stimulus-responsive polymer 4 having a small molecule compound as an adsorption site 3 is used. Then, in this embodiment, in order to increase the DBC by using such a stimulus-responsive polymer 4, it is necessary that the index A described later, which indicates the dispersibility of the carrier 2 with respect to the solvent, is 1.0 or less. As described above, the combination of the carrier 2 having the index A of 1.0 or less and the stimulus-responsive polymer 4 having the partition coefficient CLogP of −0.46 or more and 1.3 or less significantly improves DBC. .. The calculation method of the index A is specifically described below.

まず、誘電率の異なる有機溶媒相として、エタノール(誘電率ε:24.3ファラド毎メートル(F/m))及びオクタノール(誘電率ε:10.3F/m)を用意する。各溶媒へ担体2をそれぞれ分散させ、担体2と溶媒が混合するよう攪拌する。この際、担体2が溶媒中に充分分散するよう留意する。そして、各種担体2の分散液3mLをガラス製シャーレ(長径=35mm)に展開し、室温で10分静置する。その後、光学顕微鏡の倍率20倍のレンズで各種担体2に焦点を合わせ、1サンプルにつき5箇所撮像する。得られた像(20mm×27mm)の視野中に観測される担体2の凝集体部分を画像ソフトウェア(ImageJ)で二値化処理する。前記画像の凝集体部分を黒色に処理するとともに、その他を白色に処理し、黒色で得られた凝集体部分の長さ、特に長軸の長さを1つの担体2の担体径(直径)で割った値をφと定義する。そして、当該φの値に従って下記評価値1〜5までの5段階で分類する。但し、本実施形態では、担体2の担体径が3〜200μmのものを用いた場合を想定している。φの値は、1つのサンプルにつき5箇所撮像した画像から得られた値の平均値を採用する。さらに、上記の実験を1つのサンプルに対して2回繰り返し、各回について求めた評価値の2回の平均値をその担体2の評価値とする。すなわち、0.5などの値は、中間的な評価値を意味し、例えば、評価値3と評価値4の中間の評価値として3.5が位置づけられる。 First, ethanol (dielectric constant ε: 24.3 farads per meter (F / m)) and octanol (dielectric constant ε: 10.3 F / m) are prepared as organic solvent phases having different dielectric constants. The carrier 2 is dispersed in each solvent, and the mixture is stirred so that the carrier 2 and the solvent are mixed. At this time, care should be taken so that the carrier 2 is sufficiently dispersed in the solvent. Then, 3 mL of the dispersion liquid of various carriers 2 is developed on a glass petri dish (major axis = 35 mm) and allowed to stand at room temperature for 10 minutes. Then, focus on various carriers 2 with a lens having a magnification of 20 times with an optical microscope, and image at 5 points per sample. The aggregated portion of the carrier 2 observed in the field of view of the obtained image (20 mm × 27 mm) is binarized with image software (ImageJ). The aggregate portion of the image is treated black and the others are treated white, and the length of the aggregate portion obtained in black, particularly the length of the major axis, is the carrier diameter (diameter) of one carrier 2. The divided value is defined as φ. Then, according to the value of φ, the following evaluation values 1 to 5 are classified in 5 stages. However, in this embodiment, it is assumed that the carrier 2 has a carrier diameter of 3 to 200 μm. For the value of φ, the average value of the values obtained from the images taken at five points per sample is adopted. Further, the above experiment is repeated twice for one sample, and the average value of the two evaluation values obtained for each time is used as the evaluation value of the carrier 2. That is, a value such as 0.5 means an intermediate evaluation value, and for example, 3.5 is positioned as an intermediate evaluation value between the evaluation value 3 and the evaluation value 4.

評価値5:φ=0.2μm以上8.3μm未満(所見:溶媒に対し担体2が安定して良く分散している。)
評価値4:φ=8.3μm以上17μm未満(所見:担体2をよく混合することによって溶媒に対し一部が分散し、小さな凝集体及び孤立した粒子の双方が混在している。)
評価値3:φ=17μm以上27μm未満(所見:溶媒に対し担体2の一部が分散し、小さな凝集体を形成している。)
評価値2:φ=27μm以上40μm未満(所見:溶媒に対し担体2がほとんど分散せず、大きな凝集体を形成している。)
評価値1:φ=40μm以上(所見:溶媒に対し担体2が分散せず、大きな凝集体を形成している。)
Evaluation value 5: φ = 0.2 μm or more and less than 8.3 μm (Findings: Carrier 2 is stably and well dispersed in the solvent).
Evaluation value 4: φ = 8.3 μm or more and less than 17 μm (Findings: By mixing the carrier 2 well, a part of it is dispersed in the solvent, and both small aggregates and isolated particles are mixed).
Evaluation value 3: φ = 17 μm or more and less than 27 μm (Findings: A part of the carrier 2 is dispersed with respect to the solvent to form small aggregates).
Evaluation value 2: φ = 27 μm or more and less than 40 μm (Findings: Carrier 2 is hardly dispersed in the solvent, and large aggregates are formed.)
Evaluation value 1: φ = 40 μm or more (Findings: Carrier 2 is not dispersed in the solvent, forming large aggregates.)

そして、上記の基準に沿って溶媒に分散させた際の担体2の分散性を次のようにして評価する。なお、検討の結果、オクタノールに分散させたときの評価値から、エタノールに分散させたときの評価値を差し引いた値が、担体2の性質を示す値(前記した指標A)として最適であることが分かった。そこで、誘電率の値が異なるオクタノール(誘電率ε:10.3F/m)及びエタノール(誘電率ε:24.3F/m)に担体2をそれぞれ分散させて求められる評価値(評価値εオクタノール、評価値εエタノールと記載する)から、以下の式(1)に従い、指標Aを定義する。
A=評価値εオクタノール−評価値εエタノール (1)
Then, the dispersibility of the carrier 2 when dispersed in the solvent according to the above criteria is evaluated as follows. As a result of the examination, the value obtained by subtracting the evaluation value when dispersed in ethanol from the evaluation value when dispersed in octanol is optimal as the value indicating the properties of the carrier 2 (index A described above). I understood. Therefore, the evaluation value (evaluation value ε-octanol ) obtained by dispersing the carrier 2 in octanol (dielectric constant ε: 10.3 F / m) and ethanol (dielectric constant ε: 24.3 F / m) having different dielectric constant values. from to as evaluation value ε ethanol), according to the following equation (1), defines the index a.
A = Evaluation value ε- octanol -Evaluation value ε Ethanol (1)

指標Aが1.0以下である担体2に、分配係数CLogPが−0.46以上1.3以下である刺激応答性高分子4を固定化して吸着材1を製造する。そして、一実施形態として、標的物質Oである抗体を精製する場合、吸着材1が充填されたカラム20(図2参照)を用いて実施される。具体的には、カラム20の内部に充填された吸着材1へ抗体含有溶液を通液させ、必要に応じて、非特異的に吸着した成分を洗浄し、その後に溶離液を用いて吸着材1に吸着した抗体を回収することにより精製を行うことができる。通液する抗体含有溶液は、pHが7〜8の範囲であることが好ましい。本実施形態では、刺激応答性高分子4の分散性を示す指標Aが1.0以下になるように制御しているので、刺激応答性高分子4全体の親水性・疎水性のバランスを適切に制御でき、吸着部位3が担体2の表面から離間するように配置される。そのため、標的物質Oが吸着部位3に吸着し易くなり、DBCが向上する。従って、吸着材1を用いると、実際の医薬品製造プロセスや分析試薬製造プロセスなどにおいて生産性を高くすることができる。 A stimulus-responsive polymer 4 having a partition coefficient of −0.46 or more and 1.3 or less is immobilized on a carrier 2 having an index A of 1.0 or less to produce an adsorbent 1. Then, as one embodiment, when the antibody which is the target substance O is purified, it is carried out using the column 20 (see FIG. 2) packed with the adsorbent 1. Specifically, the antibody-containing solution is passed through the adsorbent 1 packed inside the column 20, and if necessary, the non-specifically adsorbed component is washed, and then the adsorbent is used with an eluent. Purification can be performed by recovering the antibody adsorbed on 1. The antibody-containing solution to be passed is preferably having a pH in the range of 7 to 8. In the present embodiment, the index A indicating the dispersibility of the stimulus-responsive polymer 4 is controlled to be 1.0 or less, so that the hydrophilicity / hydrophobic balance of the entire stimulus-responsive polymer 4 is appropriately balanced. The adsorption site 3 is arranged so as to be separated from the surface of the carrier 2. Therefore, the target substance O is easily adsorbed on the adsorption site 3, and the DBC is improved. Therefore, when the adsorbent 1 is used, the productivity can be increased in an actual drug manufacturing process, an analytical reagent manufacturing process, or the like.

次に、本実施形態に係る吸着材1について推定される標的物質Oの吸着・脱離メカニズムについて、抗体を例にして説明する。
刺激応答性高分子4の電荷が多い状態では、水中で官能基Rはより電荷を有した状態であり、電荷を有した部位どうしの電荷反発により、刺激応答性高分子4の高分子鎖5は比較的伸長した状態となる。このとき、刺激応答性高分子4に導入されている吸着部位3が疎水性の場合、親水性の刺激応答性高分子4と疎水性の吸着部位3との相互作用は比較的弱いため、吸着部位3は抗体(標的物質O)を吸着する(図1参照)。そして、溶離液が通液されるなどして外部環境の変化により刺激応答性高分子4の電荷が少なくなると、高分子鎖5の疎水性が増大する。そのため、吸着部位3が疎水性の場合、刺激応答性高分子4と吸着部位3の相互作用が強くなる方向に平衡が移動する。その結果、吸着部位3が抗体を吸着する吸着力が弱くなり、抗体が吸着部位3から脱離する。なお、ある条件で刺激応答性高分子4の電荷が少ない状態では、刺激応答性高分子4の高分子鎖5は、電荷反発が小さいため比較的収縮した状態になっている。
Next, the presumed adsorption / desorption mechanism of the target substance O for the adsorbent 1 according to the present embodiment will be described using an antibody as an example.
In the state where the stimulus-responsive polymer 4 has a large charge, the functional group R is in a more charged state in water, and the polymer chain 5 of the stimulus-responsive polymer 4 is caused by the charge repulsion between the charged sites. Is in a relatively elongated state. At this time, when the adsorption site 3 introduced into the stimulus-responsive polymer 4 is hydrophobic, the interaction between the hydrophilic stimulus-responsive polymer 4 and the hydrophobic adsorption site 3 is relatively weak, so that the adsorption site 3 is adsorbed. Site 3 adsorbs the antibody (target substance O) (see FIG. 1). Then, when the charge of the stimulus-responsive polymer 4 decreases due to a change in the external environment such as when an eluent is passed through the solution, the hydrophobicity of the polymer chain 5 increases. Therefore, when the adsorption site 3 is hydrophobic, the equilibrium shifts in the direction in which the interaction between the stimulus-responsive polymer 4 and the adsorption site 3 becomes stronger. As a result, the adsorption force at which the adsorption site 3 adsorbs the antibody is weakened, and the antibody is desorbed from the adsorption site 3. Under certain conditions, when the charge of the stimulus-responsive polymer 4 is small, the polymer chain 5 of the stimulus-responsive polymer 4 is in a relatively contracted state because the charge repulsion is small.

外部環境の変化は、刺激応答性高分子4の電荷密度及び吸着部位3と抗体との間の相互作用を変化させることができるものであれば特に限定されない。外部環境の変化は、例えば、吸着材1が接触している溶液の塩濃度、誘電率、pH、温度などの変化が挙げられる。外部環境の変化は、例えば、塩濃度が変化すると静電遮蔽効果が変化し、溶媒や溶質の種類の変化により誘電率が変化し、また、pHが変化すると電荷の平衡移動が起こり、これらによって電荷密度が変化する。外部環境の変化は、好ましくは、吸着材1が接触している溶液の塩濃度、温度、誘電率、pHの変化であり、塩濃度の変化及びpHの変化がより好ましい。これらの外部環境の変化を組み合わせてもよい。外部環境の変化により刺激応答性高分子4の電荷密度及び吸着部位3と抗体との間の相互作用が変化し、抗体が吸着又は脱離する。従って、本実施形態に係る吸着材1は、外部環境の変化に応答性の吸着材1であり、例えば、外部環境の変化がpHの変化である場合には、吸着材1はpH応答性吸着材となり、外部環境の変化が塩濃度、誘電率、温度の変化である場合には、それぞれ、塩濃度応答性吸着材、誘電率応答性吸着材、温度応答性吸着材となる。 Changes in the external environment are not particularly limited as long as they can change the charge density of the stimulus-responsive polymer 4 and the interaction between the adsorption site 3 and the antibody. Changes in the external environment include, for example, changes in the salt concentration, dielectric constant, pH, temperature, and the like of the solution with which the adsorbent 1 is in contact. Changes in the external environment include, for example, changes in the electrostatic shielding effect when the salt concentration changes, changes in the permittivity due to changes in the type of solvent and solute, and equilibrium movement of charges when the pH changes. The charge density changes. The change in the external environment is preferably a change in the salt concentration, temperature, dielectric constant, and pH of the solution with which the adsorbent 1 is in contact, and a change in the salt concentration and a change in pH are more preferable. These changes in the external environment may be combined. Due to changes in the external environment, the charge density of the stimulus-responsive polymer 4 and the interaction between the adsorption site 3 and the antibody change, and the antibody is adsorbed or desorbed. Therefore, the adsorbent 1 according to the present embodiment is an adsorbent 1 that is responsive to changes in the external environment. For example, when the change in the external environment is a change in pH, the adsorbent 1 is a pH-responsive adsorbent. When the material is changed in the external environment such as salt concentration, dielectric constant, and temperature, it becomes a salt concentration-responsive adsorbent, a dielectric-responsive adsorbent, and a temperature-responsive adsorbent, respectively.

外部環境の変化による刺激応答性高分子4の電荷密度の変化に起因するコンフォメーション変化は、抗体と吸着部位3の相互作用の強さを変化させて、吸着特性を変化させることができる程度の変化であればよい。
特に、中性付近のpHから外部刺激としてpHを上昇させた場合、担体2上の刺激応答性高分子4のコンフォメーションは伸張した形態から、徐々に収縮した形態をとると推測される。この刺激応答性高分子4のコンフォメーション変化が、物理的に抗体を吸着材1から脱離させる一助となる。またpHの変化に伴い、刺激応答性高分子4及び抗体の電荷が変化する。そのため、電荷の効果で刺激応答性高分子4に吸着していた抗体も電荷反発又は電荷の中性化によって刺激応答性高分子4、すなわち吸着材1から脱離すると考えられる。標的物質Oが抗体以外の場合も同様のメカニズムで吸着・脱離すると考えられる。
The conformational change caused by the change in the charge density of the stimulus-responsive polymer 4 due to the change in the external environment can change the strength of the interaction between the antibody and the adsorption site 3 to change the adsorption characteristics. It may be a change.
In particular, when the pH is raised from near neutral pH as an external stimulus, it is presumed that the conformation of the stimulus-responsive polymer 4 on the carrier 2 takes a gradually contracted form from an elongated form. This conformational change of the stimulus-responsive polymer 4 helps to physically desorb the antibody from the adsorbent 1. Further, as the pH changes, the charges of the stimulus-responsive polymer 4 and the antibody change. Therefore, it is considered that the antibody adsorbed on the stimulus-responsive polymer 4 due to the effect of electric charge is also desorbed from the stimulus-responsive polymer 4, that is, the adsorbent 1 by charge repulsion or charge neutralization. When the target substance O is other than an antibody, it is considered that it is adsorbed and desorbed by the same mechanism.

以上から、刺激応答性高分子4中の吸着部位導入量、すなわち官能基量を変化させることで電荷の帯電量をコントロールすることができ、刺激応答性高分子4の親水性・疎水性を制御することができる。前述したように、刺激応答性高分子4の親水性・疎水性を示す指標は分配係数CLogPで表される。 From the above, the amount of charge charged can be controlled by changing the amount of adsorption site introduced in the stimulus-responsive polymer 4, that is, the amount of functional groups, and the hydrophilicity and hydrophobicity of the stimulus-responsive polymer 4 can be controlled. can do. As described above, the index indicating the hydrophilicity / hydrophobicity of the stimulus-responsive polymer 4 is represented by the partition coefficient CLogP.

一般的に、担体2の分散度を示す指標Aが高い場合では、標的物質Oの界面と吸着部位3との間で相互作用が生じ、抗体の吸着が阻害されることで吸着能が大幅に低減することが知られている。しかし、本実施形態における刺激応答性高分子4は、担体2の界面性質、すなわち分散度を示す指標Aが高い場合においても、刺激応答性高分子4の分配係数CLogPを最適な範囲で適用することで、高効率に抗体を吸着することができる。 Generally, when the index A indicating the dispersity of the carrier 2 is high, an interaction occurs between the interface of the target substance O and the adsorption site 3, and the adsorption of the antibody is inhibited, so that the adsorption ability is significantly increased. It is known to reduce. However, the stimulus-responsive polymer 4 in the present embodiment applies the partition coefficient CLogP of the stimulus-responsive polymer 4 in the optimum range even when the interfacial property of the carrier 2, that is, the index A indicating the degree of dispersion is high. Therefore, the antibody can be adsorbed with high efficiency.

具体的には、担体2の指標Aが高い場合、例えば、担体2の指標Aが0.5の場合に、分配係数CLogPが0.19程度の低い値の刺激応答性高分子4を組み合わせることで、抗体のDBCを約30mg/mLとすることができる。これは、刺激応答性高分子4中の官能基量が多いため、分子間で電荷が反発し、担体2の界面の影響以上の相互作用で担体2の界面ではなく溶液界面側へ吸着部位3が露出することによって得られるものである。そして、これにより、抗体の吸着能が向上する。また、担体2の指標Aが高い、すなわち疎水的な界面性質を有する担体2にアミノ基などの官能基量が多い刺激応答性高分子4を固定化することで担体2の表面の性質を改質でき、抗体の吸着能が向上する。 Specifically, when the index A of the carrier 2 is high, for example, when the index A of the carrier 2 is 0.5, the stimulus-responsive polymer 4 having a low partition coefficient CLogP of about 0.19 is combined. Therefore, the DBC of the antibody can be set to about 30 mg / mL. This is because the amount of functional groups in the stimulus-responsive polymer 4 is large, so that the charge repels between the molecules, and the adsorption site 3 is not on the interface of the carrier 2 but on the solution interface side due to the interaction beyond the influence of the interface of the carrier 2. Is obtained by exposing. As a result, the adsorption ability of the antibody is improved. Further, the surface properties of the carrier 2 are improved by immobilizing the stimulus-responsive polymer 4 having a large amount of functional groups such as amino groups on the carrier 2 having a high index A of the carrier 2, that is, having a hydrophobic interfacial property. It can be improved and the adsorption capacity of the antibody is improved.

一方、担体2の指標Aが低い場合、すなわち担体2が親水性である場合は、標的物質Oの界面と吸着部位3との間で相互作用は生じないか又は生じ難い。そのため、担体2の指標Aが高い場合と比較して高い自由度で刺激応答性高分子4を選択し、組み合わせることができる。例えば、担体2の指標Aが−2.5〜−3.5の場合、分配係数CLogPが1.3以下である刺激応答性高分子4であればどのようなものも用いることができる。 On the other hand, when the index A of the carrier 2 is low, that is, when the carrier 2 is hydrophilic, the interaction between the interface of the target substance O and the adsorption site 3 does not occur or is unlikely to occur. Therefore, the stimulus-responsive polymer 4 can be selected and combined with a higher degree of freedom as compared with the case where the index A of the carrier 2 is high. For example, when the index A of the carrier 2 is -2.5 to -3.5, any stimulus-responsive polymer 4 having a partition coefficient CLogP of 1.3 or less can be used.

他の使用態様として、吸着材1は懸濁液の状態で用いることができる。従来の溶解度の変化を利用する温度応答性の吸着材では、温度変化によって疎水性が増大して分散性が低下する。そして、懸濁状態の吸着材が凝集し、壁面に付着して界面に局在化等するリスクが高い。しかし、このような使用態様であっても、本実施形態に係る吸着材1は、温度変化に伴う溶解度の変化を抗体の吸着又は脱離に利用していないため、そのようなリスクはほぼない。 As another usage mode, the adsorbent 1 can be used in a suspension state. In the conventional temperature-responsive adsorbent that utilizes a change in solubility, the hydrophobicity increases and the dispersibility decreases due to the temperature change. Then, there is a high risk that the adsorbent in the suspended state aggregates, adheres to the wall surface, and is localized at the interface. However, even in such a usage mode, the adsorbent 1 according to the present embodiment does not utilize the change in solubility due to the temperature change for the adsorption or desorption of the antibody, so that there is almost no such risk. ..

<カラム及び精製装置>
図2は、本実施形態に係るカラム20の構成を説明する概略図である。図3は、本実施形態に係る精製装置30の構成を説明する概略図である。なお、カラム20及び精製装置30の説明において、吸着材1に関して既に詳述している要素についてはその説明を省略する。
<Column and purification equipment>
FIG. 2 is a schematic view illustrating the configuration of the column 20 according to the present embodiment. FIG. 3 is a schematic view illustrating the configuration of the purification apparatus 30 according to the present embodiment. In the description of the column 20 and the purification apparatus 30, the description of the elements already described in detail with respect to the adsorbent 1 will be omitted.

図2に示すように、カラム20は、有底の筒状体21内に吸着材1が充填されたものである。なお、筒状体21の底部には図示しない排出口が設けられており、カラム20内を通液した各種溶液がこの排出口から排出される。このカラム20は、培養時に含まれる複数の夾雑物の中から抗体などの標的物質Oを選択的に回収し純度を高める装置である。 As shown in FIG. 2, the column 20 is formed by filling the bottomed tubular body 21 with the adsorbent 1. A discharge port (not shown) is provided at the bottom of the tubular body 21, and various solutions that have passed through the column 20 are discharged from this discharge port. The column 20 is a device for selectively recovering a target substance O such as an antibody from a plurality of impurities contained during culturing to increase the purity.

また、図3に示すように、精製装置30は、吸着材1が充填されたカラム20を備えている。例えば、精製装置30は、図3に示すように、培養槽31と、カラム20と、回収容器32とを備えている。
なお、培養槽31は、標的物質Oを細胞培養によって産生させる装置である。回収容器32は、カラム20で精製された標的物質Oを含む溶液を回収する容器である。培養槽31や回収容器32は公知のものを用いることができる。
なお、精製装置30はこれら以外にも標的物質Oに応じた精製に必要な様々な装置を備えているが、それらの装置の説明は省略する。
Further, as shown in FIG. 3, the purification apparatus 30 includes a column 20 filled with the adsorbent 1. For example, the purification apparatus 30 includes a culture tank 31, a column 20, and a recovery container 32, as shown in FIG.
The culture tank 31 is a device for producing the target substance O by cell culture. The recovery container 32 is a container for collecting the solution containing the target substance O purified in the column 20. Known culture tanks 31 and recovery containers 32 can be used.
In addition to these, the purification device 30 is provided with various devices necessary for purification according to the target substance O, but the description of these devices will be omitted.

<吸着材の製造方法>
本実施形態に係る吸着材1は、刺激応答性高分子4を担体2に固定化することで製造できる。刺激応答性高分子4は、好ましくは、化学結合を介して担体2に結合させる。すなわち、一実施形態において、吸着材1は、刺激応答性高分子4と担体2とが化学結合を介して固定化されている。吸着部位3は、複数個の官能基Rを有する高分子鎖5を担体2に固定化する前又は固定化した後のいずれの時点で導入してもよい。すなわち、吸着部位3を複数個の官能基Rを有する高分子鎖5に導入した後、吸着部位3が導入された高分子鎖5を担体2に固定化してもよい。また、吸着部位3を有さない複数個の官能基Rを有する高分子鎖5を担体2に固定化した後、高分子鎖5に吸着部位3を導入してもよい。また、吸着部位3を導入した後の高分子鎖5中に残存する官能基Rに対して、親水もしくは疎水的な置換基をさらに導入してもよい。
<Manufacturing method of adsorbent>
The adsorbent 1 according to the present embodiment can be produced by immobilizing the stimulus-responsive polymer 4 on the carrier 2. The stimulus-responsive polymer 4 is preferably bound to the carrier 2 via a chemical bond. That is, in one embodiment, in the adsorbent 1, the stimulus-responsive polymer 4 and the carrier 2 are immobilized via chemical bonds. The adsorption site 3 may be introduced at any time before or after the polymer chain 5 having a plurality of functional groups R is immobilized on the carrier 2. That is, after introducing the adsorption site 3 into the polymer chain 5 having a plurality of functional groups R, the polymer chain 5 into which the adsorption site 3 is introduced may be immobilized on the carrier 2. Further, the adsorption site 3 may be introduced into the polymer chain 5 after the polymer chain 5 having a plurality of functional groups R having no adsorption site 3 is immobilized on the carrier 2. Further, a hydrophilic or hydrophobic substituent may be further introduced into the functional group R remaining in the polymer chain 5 after the adsorption site 3 is introduced.

以上に説明した本実施形態に係る吸着材1、カラム20及び精製装置30は、担体2が、誘電率の異なるオクタノール及びエタノールに分散させた際、それぞれの溶媒に対する担体2の分散性を示す評価値から算出される指標Aが1.0以下であり、かつ刺激応答性高分子4が、分配係数CLogPが−0.46以上1.3以下であることとしている。吸着材1、カラム20及び精製装置30は、このような構成としているので、親水性や疎水性など様々な界面性質を有する担体2に対して刺激応答性高分子4全体の親水性・疎水性のバランスを制御しつつ吸着部位3の吸着能を高く維持したまま固定化することができる。従って、吸着材1、カラム20及び精製装置30は、吸着部位3として低分子化合物を用いることができるとともに従来よりも多くの種類の担体2を用いることができ、かつ、標的物質Oの吸着容量を高くできる。そして、これにより、吸着材1、カラム20及び精製装置30を用いると、例えば、抗体医薬品や分析試薬の製造コストを低減することが可能であり、また、生産性を向上させることもできる。
また、本実施形態に係る吸着材1の製造方法は、前記した吸着材1を確実に製造することができる。
The adsorbent 1, the column 20 and the purification apparatus 30 according to the present embodiment described above are evaluated to show the dispersibility of the carrier 2 in each solvent when the carrier 2 is dispersed in octanol and ethanol having different dielectric constants. The index A calculated from the value is 1.0 or less, and the stimulus-responsive polymer 4 has a partition coefficient CLogP of −0.46 or more and 1.3 or less. Since the adsorbent 1, the column 20, and the purification device 30 have such a configuration, the hydrophilicity and hydrophobicity of the entire stimulus-responsive polymer 4 to the carrier 2 having various interfacial properties such as hydrophilicity and hydrophobicity. It is possible to immobilize the adsorption site 3 while maintaining a high adsorption capacity while controlling the balance between the two. Therefore, the adsorbent 1, the column 20, and the purification apparatus 30 can use a small molecule compound as the adsorption site 3, can use more types of carriers 2 than before, and have an adsorption capacity of the target substance O. Can be raised. As a result, by using the adsorbent 1, the column 20, and the purification apparatus 30, for example, it is possible to reduce the production cost of the antibody drug or the analytical reagent, and it is also possible to improve the productivity.
In addition, the method for producing the adsorbent 1 according to the present embodiment can reliably produce the adsorbent 1 described above.

以下、実施例を示して本発明について具体的に説明するが、本発明の技術的範囲はこれに限定されるものではない。 Hereinafter, the present invention will be specifically described with reference to examples, but the technical scope of the present invention is not limited thereto.

〔1〕刺激応答性高分子の合成
<No.P1に係る刺激応答性高分子の合成>
複数のアミノ基を有する高分子としてε−ポリリジン(EPL)を用いた。また、前記アミノ基に導入する吸着部位としてメルカプトベンゾチアゾール酢酸(MBTA、2−ベンゾチアゾリルチオ酢酸)を用いた。なお、MBTAは、抗体吸着能を有するチオフィリック系の化合物である。
[1] Synthesis of stimulus-responsive polymer <No. Synthesis of stimulus-responsive polymer related to P1>
Ε-Polylysine (EPL) was used as a polymer having a plurality of amino groups. In addition, mercaptobenzothiazole acetic acid (MBTA, 2-benzothiazolylthioacetic acid) was used as an adsorption site to be introduced into the amino group. MBTA is a thiophylic compound having an antibody-adsorbing ability.

EPL(一丸ファルコス社製、ポリリジン10)の水/ジメチルホルムアミド(DMF)溶液(水:DMF=1:2(体積比))にMBTA(0.7当量)及び脱水縮合剤の4−(4,6−ジメトキシ−1,3,5−トリアジン−2−イル)−4−メチルモルホリニウムクロリド(DMT−MM)(1.2当量)を加え、室温で5時間攪拌し、EPLのアミノ基とMBTAのカルボキシル基との反応によりアミド結合を形成することで、EPLにMBTAを導入した。得られた反応液に塩酸を加えて酸性とし、テトラヒドロフラン(THF)により透析し、生じた沈殿を濾別した後にエバポレーターで乾燥させることにより、No.P1に係る刺激応答性高分子(以下、サンプルナンバーに応じて「刺激応答性高分子P1」などと呼称する)を固体として得た。 EPL (Ichimaru Falcos, Polylysine 10) in water / dimethylformamide (DMF) solution (water: DMF = 1: 2 (volume ratio)) with MBTA (0.7 equivalent) and dehydration condensing agent 4- (4, 6-Dimethoxy-1,3,5-triazine-2-yl) -4-methylmorpholinium chloride (DMT-MM) (1.2 equivalent) was added, and the mixture was stirred at room temperature for 5 hours with the amino group of EPL. MBTA was introduced into EPL by forming an amide bond by reacting with the carboxyl group of MBTA. Hydrochloric acid was added to the obtained reaction solution to make it acidic, dialyzed against tetrahydrofuran (THF), and the resulting precipitate was filtered off and then dried with an evaporator to obtain No. A stimulus-responsive polymer according to P1 (hereinafter, referred to as “stimulus-responsive polymer P1” or the like according to the sample number) was obtained as a solid.

<刺激応答性高分子P2の合成>
刺激応答性高分子P1と同様に、EPLの水/DMF溶液にMBTA(0.6当量)及びDMT−MM(1.2当量)を加え、室温で5時間攪拌した。そして、刺激応答性高分子P1と同様の手順で生じさせた沈殿を濾別し、これをエバポレーターで乾燥させることにより、刺激応答性高分子P2を得た。
<Synthesis of stimulus-responsive polymer P2>
MBTA (0.6 eq) and DMT-MM (1.2 eq) were added to a water / DMF solution of EPL in the same manner as for the stimulus-responsive polymer P1, and the mixture was stirred at room temperature for 5 hours. Then, the precipitate generated in the same procedure as the stimulus-responsive polymer P1 was filtered off, and this was dried with an evaporator to obtain a stimulus-responsive polymer P2.

<刺激応答性高分子P3の合成>
刺激応答性高分子P1と同様に、EPLの水/DMF溶液にMBTA(0.45当量)及びDMT−MM(1.2当量)を加え、室温で5時間攪拌した。そして、刺激応答性高分子P1と同様の手順で生じさせた沈殿を濾別し、これをエバポレーターで乾燥させることにより、刺激応答性高分子P3を得た。
<Synthesis of stimulus-responsive polymer P3>
MBTA (0.45 eq) and DMT-MM (1.2 eq) were added to the water / DMF solution of EPL in the same manner as for the stimulus-responsive polymer P1, and the mixture was stirred at room temperature for 5 hours. Then, the precipitate formed in the same procedure as the stimulus-responsive polymer P1 was filtered off, and this was dried with an evaporator to obtain a stimulus-responsive polymer P3.

<刺激応答性高分子P4の合成>
刺激応答性高分子P1と同様に、EPLの水/DMF溶液にMBTA(0.3当量)及びDMT−MM(1.2当量)を加え、室温で5時間攪拌した。そして、刺激応答性高分子P1と同様の手順で生じさせた沈殿を濾別し、これをエバポレーターで乾燥させることにより、刺激応答性高分子P4を得た。
<Synthesis of stimulus-responsive polymer P4>
MBTA (0.3 eq) and DMT-MM (1.2 eq) were added to the water / DMF solution of EPL in the same manner as for the stimulus-responsive polymer P1, and the mixture was stirred at room temperature for 5 hours. Then, the precipitate formed in the same procedure as the stimulus-responsive polymer P1 was filtered off, and this was dried with an evaporator to obtain a stimulus-responsive polymer P4.

<刺激応答性高分子P5の合成>
刺激応答性高分子P1と同様に、EPLの水/DMF溶液にMBTA(0.07当量)及びDMT−MM(1.2当量)を加え、室温で5時間攪拌した。そして、刺激応答性高分子P1と同様の手順で生じさせた沈殿を濾別し、これをエバポレーターで乾燥させることにより、刺激応答性高分子P5を得た。
<Synthesis of stimulus-responsive polymer P5>
MBTA (0.07 eq) and DMT-MM (1.2 eq) were added to a water / DMF solution of EPL in the same manner as for the stimulus-responsive polymer P1, and the mixture was stirred at room temperature for 5 hours. Then, the precipitate generated in the same procedure as the stimulus-responsive polymer P1 was filtered off, and this was dried with an evaporator to obtain a stimulus-responsive polymer P5.

<刺激応答性高分子P6の合成>
刺激応答性高分子P1と同様に、EPLの水/DMF溶液にMBTA(0.9当量)及びDMT−MM(1.2当量)を加え、室温で5時間攪拌した。そして、刺激応答性高分子P1と同様の手順で生じさせた沈殿を濾別し、これをエバポレーターで乾燥させることにより、刺激応答性高分子P6を得た。
<Synthesis of stimulus-responsive polymer P6>
MBTA (0.9 eq) and DMT-MM (1.2 eq) were added to the water / DMF solution of EPL in the same manner as for the stimulus-responsive polymer P1, and the mixture was stirred at room temperature for 5 hours. Then, the precipitate generated in the same procedure as the stimulus-responsive polymer P1 was filtered off, and this was dried with an evaporator to obtain a stimulus-responsive polymer P6.

<刺激応答性高分子P7の合成>
刺激応答性高分子P1と同様に、EPLの水/DMF溶液にMBTA(0.03当量)及びDMT−MM(1.2当量)を加え、室温で5時間攪拌した。そして、刺激応答性高分子P1と同様の手順で生じさせた沈殿を濾別し、これをエバポレーターで乾燥させることにより、刺激応答性高分子P7を得た。
<Synthesis of stimulus-responsive polymer P7>
MBTA (0.03 eq) and DMT-MM (1.2 eq) were added to a water / DMF solution of EPL in the same manner as for the stimulus-responsive polymer P1, and the mixture was stirred at room temperature for 5 hours. Then, the precipitate generated in the same procedure as the stimulus-responsive polymer P1 was filtered off, and this was dried with an evaporator to obtain a stimulus-responsive polymer P7.

<刺激応答性高分子P1〜7の化学組成評価と分配係数>
刺激応答性高分子P1〜7の組成、吸着部位導入率、1分子当たりの吸着部位導入量及び分配係数CLogPを表1に示す。表1において、組成については、吸着部位の導入に用いた原料化合物を記載している。吸着部位導入率は、複数のアミノ基を有する高分子のアミノ基量に対し吸着部位により占有された割合を示している。吸着部位導入率は、H−NMR測定によって求めた。1分子当たりの吸着部位導入量は、用いたEPLの有するアミノ基数と吸着部位導入率の積によって求めた。また、化学構造式作画ソフトウェアChemDrawで刺激応答性高分子P1〜7の分配係数CLogPを算出した。
<Chemical composition evaluation and partition coefficient of stimulus-responsive polymers P1-7>
Table 1 shows the composition of the stimulus-responsive polymers P1 to 7, the adsorption site introduction rate, the adsorption site introduction amount per molecule, and the partition coefficient CLogP. In Table 1, as for the composition, the raw material compounds used for introducing the adsorption site are listed. The adsorption site introduction rate indicates the ratio occupied by the adsorption site with respect to the amount of amino groups of the polymer having a plurality of amino groups. The adsorption site introduction rate was determined by 1 1 H-NMR measurement. The amount of adsorption site introduced per molecule was determined by the product of the number of amino groups possessed by the EPL used and the adsorption site introduction rate. In addition, the partition coefficient CLogP of the stimulus-responsive polymers P1 to 7 was calculated using the chemical structural formula drawing software ChemDraw.

Figure 0006927259
Figure 0006927259

〔2〕担体
No.C1〜9に係る担体(以下、サンプルナンバーに応じて「担体C1」などと呼称する)を用意した(表2参照)。なお、担体は、ポリスチレンやアクリル、メタクリレート系の樹脂担体、多糖類のSepharose担体、シリカ、磁性体の無機酸化物(磁性微粒子)などを用いた。また、誘電率の値が異なる有機溶媒相として、オクタノール(誘電率ε:10.3F/m)及びエタノール(誘電率ε:24.3F/m)を用意した。そして、各種担体をそれぞれこれらの有機溶媒相に分散させ、担体と溶媒とをよく混合させた。そして、各種担体の分散液3mLをガラス製シャーレ(長径=35mm)に展開し、室温で10分静置させた。その後、光学顕微鏡の倍率20倍のレンズで各種担体に焦点を合わせ、1サンプルにつき5箇所撮像した。得られた像(20mm×27mm)の視野中に観測される担体の凝集体部分を画像ソフトウェア(ImageJ)で二値化処理した。前記画像の凝集体部分を黒色に処理し、その他を白色に処理し、黒色で得られた凝集体部分の長さ、特に長軸の長さを1つの担体の担体径(直径)で割った値をφと定義した。そして、当該φの値に従って下記評価値1〜5までの5段階で分類した。φの値は、1つのサンプルにつき5箇所撮像した画像から得られた値の平均値を採用した。さらに、上記の実験を1つのサンプルに対して2回繰り返し、各回について求めた評価値の2回の平均値をその担体の評価値とした。
[2] Carrier No. Carriers related to C1 to 9 (hereinafter, referred to as "carrier C1" or the like according to the sample number) were prepared (see Table 2). As the carrier, polystyrene, acrylic, methacrylate-based resin carrier, polysaccharide Sepharose carrier, silica, magnetic inorganic oxide (magnetic fine particles) and the like were used. Further, octanol (dielectric constant ε: 10.3 F / m) and ethanol (dielectric constant ε: 24.3 F / m) were prepared as organic solvent phases having different dielectric constant values. Then, each of the various carriers was dispersed in these organic solvent phases, and the carrier and the solvent were mixed well. Then, 3 mL of the dispersion liquid of various carriers was developed on a glass petri dish (major axis = 35 mm) and allowed to stand at room temperature for 10 minutes. Then, the focus was on various carriers with a lens having a magnification of 20 times with an optical microscope, and five points were imaged per sample. The aggregate portion of the carrier observed in the field of view of the obtained image (20 mm × 27 mm) was binarized with image software (ImageJ). The aggregate portion of the image was treated black, the others were treated white, and the length of the aggregate portion obtained in black, particularly the length of the major axis, was divided by the carrier diameter (diameter) of one carrier. The value was defined as φ. Then, according to the value of φ, the following evaluation values 1 to 5 were classified in 5 stages. As the value of φ, the average value of the values obtained from the images taken at 5 points per sample was adopted. Further, the above experiment was repeated twice for one sample, and the average value of the two evaluation values obtained for each time was used as the evaluation value of the carrier.

評価値5:φ=0.2μm以上8.3μm未満(所見:溶媒に対し担体が安定して良く分散している。)
評価値4:φ=8.3μm以上17μm未満(所見:担体をよく混合することによって溶媒に対し一部が分散し、小さな凝集体及び孤立した粒子の双方が混在している。)
評価値3:φ=17μm以上27μm未満(所見:溶媒に対し担体の一部が分散し、小さな凝集体を形成している。)
評価値2:φ=27μm以上40μm未満(所見:溶媒に対し担体がほとんど分散せず、大きな凝集体を形成している。)
評価値1:φ=40μm以上(所見:溶媒に対し担体が分散せず、大きな凝集体を形成している。)
Evaluation value 5: φ = 0.2 μm or more and less than 8.3 μm (Findings: The carrier is stably and well dispersed in the solvent).
Evaluation value 4: φ = 8.3 μm or more and less than 17 μm (Findings: By mixing the carrier well, a part is dispersed in the solvent, and both small aggregates and isolated particles are mixed).
Evaluation value 3: φ = 17 μm or more and less than 27 μm (Findings: A part of the carrier is dispersed with respect to the solvent to form small aggregates)
Evaluation value 2: φ = 27 μm or more and less than 40 μm (Findings: The carrier is hardly dispersed in the solvent, and large aggregates are formed.)
Evaluation value 1: φ = 40 μm or more (Findings: The carrier is not dispersed in the solvent and large aggregates are formed.)

そして、上記の基準に沿って溶媒に分散させた際の担体の分散性を次のようにして評価した。そして、誘電率の値が異なるオクタノール(誘電率ε:10.3F/m)及びエタノール(誘電率ε:24.3F/m)に担体をそれぞれ分散させて求められる評価値(評価値εオクタノール、評価値εエタノール)から、以下の式(1)に従い、指標Aを定義した。
A=評価値εオクタノール−評価値εエタノール (1)
表2に担体C1〜9の材質と、平均粒子径(μm)、指標Aに関する評価結果を示す。
Then, the dispersibility of the carrier when dispersed in the solvent according to the above criteria was evaluated as follows. Then, the evaluation values (evaluation value ε-octanol , which are obtained by dispersing the carriers in octanol (dielectric constant ε: 10.3 F / m) and ethanol (dielectric constant ε: 24.3 F / m) having different dielectric constant values, respectively. from the evaluation value ε ethanol), according to the following equation (1), defines the index a.
A = Evaluation value ε- octanol -Evaluation value ε Ethanol (1)
Table 2 shows the evaluation results regarding the materials of the carriers C1 to 9, the average particle size (μm), and the index A.

Figure 0006927259
Figure 0006927259

担体C1〜4、9(担体A群)と比較して、担体C5〜8(担体B群)はエタノールに良く分散し、オクタノールでは凝集体を形成した。そのため、担体B群は、より親水的であることが判明した。 Compared with carriers C1 to 4 and 9 (carrier A group), carriers C5 to 8 (carrier B group) dispersed well in ethanol, and aggregates were formed in octanol. Therefore, the carrier B group was found to be more hydrophilic.

〔3〕実施例1〜9及び比較例1〜3に係る吸着材の調製と抗体吸着能評価
担体C1〜9と刺激応答性高分子P1〜7とを後記する表3の組合せで固定化して抗体の吸着能評価を行った。刺激応答性高分子P1〜7を担体C1〜9に固定化するため、担体C1〜9の官能基としてエポキシ基、カルボキシル基を使用した。また、必要な場合にはこれらの官能基を修飾した。
[3] Preparation of Adsorbents and Evaluation of Antibody Adsorption Ability According to Examples 1 to 9 and Comparative Examples 1 to 3 Carriers C1 to 9 and stimulus-responsive polymers P1 to 7 were immobilized by the combination shown in Table 3 described later. The adsorption capacity of the antibody was evaluated. In order to immobilize the stimulus-responsive polymers P1 to 7 on the carriers C1 to 9, an epoxy group and a carboxyl group were used as the functional groups of the carriers C1 to 9. In addition, these functional groups were modified if necessary.

<実施例1>
<担体C1(担体A群)上へ刺激応答性高分子P3を固定化した吸着材の調製>
THF/水混合溶液(THF:水=4:1(体積比))を溶媒として用い、刺激応答性高分子P3の1質量%溶液を調製した。この刺激応答性高分子P3の溶液と、カルボキシル基を表面に有する平均粒子径100μmのポリスチレン担体(テクノケミカル社製、ポリビーズ ポリスチレンシリーズ)と、DMT−MM(10当量)とから得られた懸濁液を室温で一晩振盪させた。その後、THF/水混合溶媒で洗浄し、刺激応答性高分子P3が担体C1に固定化された実施例1に係る吸着材を得た。
<Example 1>
<Preparation of an adsorbent in which a stimulus-responsive polymer P3 is immobilized on carrier C1 (carrier A group)>
A 1% by mass solution of the stimulus-responsive polymer P3 was prepared using a THF / water mixed solution (THF: water = 4: 1 (volume ratio)) as a solvent. Suspension obtained from a solution of this stimulus-responsive polymer P3, a polystyrene carrier having a carboxyl group on the surface and an average particle size of 100 μm (Polybeads polystyrene series manufactured by Technochemical Co., Ltd.), and DMT-MM (10 equivalents). The solution was shaken overnight at room temperature. Then, it was washed with a mixed solvent of THF / water to obtain the adsorbent according to Example 1 in which the stimulus-responsive polymer P3 was immobilized on the carrier C1.

<実施例1に係る吸着材の抗体吸着能評価>
実施例1に係る吸着材の吸着部位の抗体吸着能を評価するため、以下の手順に従い実験を行った。具体的には、実施例1に係る吸着材を1mL分カラムに充填し、1質量%の所定のヒトIgGを含むpH7.4のリン酸緩衝液(PBS緩衝液)を5mL通液した。そして、カラムから溶出される溶液内のヒトIgG濃度をモニタリングして、10%の抗体溶液がカラムから漏れだす溶液量から抗体吸着能を算出した。ここでいう抗体吸着能とは、吸着材への動的抗体吸着容量(10%DBC)と定義する。その結果を後記表3及び図4に示す。なお、図4は、実施例1〜9及び比較例1〜3に係る各吸着材における指標Aと10%DBCとの関係を示すグラフである。
表3及び図4に示すように、実施例1に係る吸着材1mLに対し、24mgの抗体が吸着することが確認された。実施例1に係る吸着材は、担体と刺激応答性高分子の組合せが良かったため、高効率で抗体を吸着できることが確認された。
<Evaluation of antibody adsorption ability of adsorbent according to Example 1>
In order to evaluate the antibody adsorption ability of the adsorption site of the adsorbent according to Example 1, an experiment was conducted according to the following procedure. Specifically, the adsorbent according to Example 1 was filled in a column for 1 mL, and 5 mL of a phosphate buffer solution (PBS buffer solution) having a pH of 7.4 containing 1% by mass of a predetermined human IgG was passed through the column. Then, the human IgG concentration in the solution eluted from the column was monitored, and the antibody adsorption capacity was calculated from the amount of the solution in which the 10% antibody solution leaked from the column. The antibody adsorption capacity referred to here is defined as the dynamic antibody adsorption capacity (10% DBC) on the adsorbent. The results are shown in Table 3 and FIG. 4 below. Note that FIG. 4 is a graph showing the relationship between the index A and 10% DBC in each of the adsorbents according to Examples 1 to 9 and Comparative Examples 1 to 3.
As shown in Table 3 and FIG. 4, it was confirmed that 24 mg of the antibody was adsorbed on 1 mL of the adsorbent according to Example 1. It was confirmed that the adsorbent according to Example 1 could adsorb the antibody with high efficiency because the combination of the carrier and the stimulus-responsive polymer was good.

以上の結果から、分散度を示す指標Aが0の担体C1と、分配係数CLogPが0.62の刺激応答性高分子P3とを組み合わせたとき、10%DBCは24mg/mLであり、市販品として流通する吸着材の最低限の機能20mg/mL以上が得られることが明らかとなった。これは、担体と刺激応答性高分子の組合せが良かったためと考えられた。 From the above results, when the carrier C1 having an index A indicating the degree of dispersibility of 0 and the stimulus-responsive polymer P3 having a distribution coefficient CLogP of 0.62 are combined, the 10% DBC is 24 mg / mL, which is a commercially available product. It has been clarified that the minimum function of the adsorbent distributed as 20 mg / mL or more can be obtained. It was considered that this was because the combination of the carrier and the stimulus-responsive polymer was good.

<実施例2>
<担体C2(担体A群)上へ刺激応答性高分子P4を固定化した吸着材の調製>
THF/水混合溶液(THF:水=2:1(体積比))を溶媒として用い、刺激応答性高分子P4の1質量%溶液を調製した。この刺激応答性高分子P4の溶液と、カルボキシル基を表面に有する平均粒子径50μmのポリスチレン担体(テクノケミカル社製、ポリビーズ ポリスチレンシリーズ)と、DMT−MM(10当量)とから得られた懸濁液を室温で一晩振盪させた。その後、THF/水混合溶媒で洗浄し、刺激応答性高分子P4が担体C2に固定化された実施例2に係る吸着材を得た。
<Example 2>
<Preparation of an adsorbent in which a stimulus-responsive polymer P4 is immobilized on carrier C2 (carrier A group)>
A 1% by mass solution of the stimulus-responsive polymer P4 was prepared using a THF / water mixed solution (THF: water = 2: 1 (volume ratio)) as a solvent. Suspension obtained from a solution of this stimulus-responsive polymer P4, a polystyrene carrier having a carboxyl group on the surface and an average particle size of 50 μm (Polybeads polystyrene series manufactured by Technochemical Co., Ltd.), and DMT-MM (10 equivalents). The solution was shaken overnight at room temperature. Then, it was washed with a mixed solvent of THF / water to obtain the adsorbent according to Example 2 in which the stimulus-responsive polymer P4 was immobilized on the carrier C2.

<実施例2に係る吸着材の抗体吸着能評価>
実施例2に係る吸着材の吸着部位の抗体吸着能を評価するため、実施例1に係る吸着材と同様の手順で同様の実験を行った。その結果を後記表3及び図4に示す。
表3及び図4に示すように、実施例2に係る吸着材1mLに対し、30mgの抗体が吸着することが確認された。
<Evaluation of antibody adsorption ability of adsorbent according to Example 2>
In order to evaluate the antibody adsorbing ability of the adsorbent site of the adsorbent according to Example 2, the same experiment was conducted in the same procedure as that of the adsorbent according to Example 1. The results are shown in Table 3 and FIG. 4 below.
As shown in Table 3 and FIG. 4, it was confirmed that 30 mg of the antibody was adsorbed on 1 mL of the adsorbent according to Example 2.

以上の結果から、分散度を示す指標Aが0.5の担体C2と、分配係数CLogPが0.19の刺激応答性高分子P4とを組み合わせたとき、10%DBCは30mg/mLと高い値が得られた。これは、担体と刺激応答性高分子の組合せが良かったためと考えられた。 From the above results, when the carrier C2 having an index A indicating the degree of dispersion of 0.5 and the stimulus-responsive polymer P4 having a partition coefficient CLogP of 0.19 are combined, the 10% DBC is as high as 30 mg / mL. was gotten. It was considered that this was because the combination of the carrier and the stimulus-responsive polymer was good.

<実施例3>
<担体C3(担体A群)上へ刺激応答性高分子P4を固定化した吸着材の調製>
THF/水混合溶液(THF:水=2:1(体積比))を溶媒として用い、刺激応答性高分子P4の1質量%溶液を調製した。この刺激応答性高分子P4の溶液と、カルボキシル基を表面に有する平均粒子径30μmのアクリル担体(Soken社製、MXシリーズ)と、DMT−MM(10当量)とから得られた懸濁液を室温で一晩振盪させた。その後、THF/水混合溶媒で洗浄し、刺激応答性高分子P4が担体C3に固定化された実施例3に係る吸着材を得た。
<Example 3>
<Preparation of an adsorbent in which a stimulus-responsive polymer P4 is immobilized on carrier C3 (carrier A group)>
A 1% by mass solution of the stimulus-responsive polymer P4 was prepared using a THF / water mixed solution (THF: water = 2: 1 (volume ratio)) as a solvent. A suspension obtained from a solution of this stimulus-responsive polymer P4, an acrylic carrier having a carboxyl group on the surface and an average particle size of 30 μm (MX series manufactured by Soken), and DMT-MM (10 equivalents). It was shaken overnight at room temperature. Then, it was washed with a mixed solvent of THF / water to obtain the adsorbent according to Example 3 in which the stimulus-responsive polymer P4 was immobilized on the carrier C3.

<実施例3に係る吸着材の抗体吸着能評価>
実施例3に係る吸着材の吸着部位の抗体吸着能を評価するため、実施例1に係る吸着材と同様の手順で同様の実験を行った。その結果を後記表3及び図4に示す。
表3及び図4に示すように、実施例3に係る吸着材1mLに対し、32mgの抗体が吸着することが確認された。
<Evaluation of antibody adsorption ability of adsorbent according to Example 3>
In order to evaluate the antibody adsorbing ability of the adsorbing site of the adsorbent according to Example 3, the same experiment was conducted in the same procedure as that of the adsorbent according to Example 1. The results are shown in Table 3 and FIG. 4 below.
As shown in Table 3 and FIG. 4, it was confirmed that 32 mg of the antibody was adsorbed on 1 mL of the adsorbent according to Example 3.

以上の結果から、分散度を示す指標Aが0.5の担体C3と、分配係数CLogPが0.19の刺激応答性高分子P4とを組み合わせたとき、10%DBCは32mg/mLと高い値が得られた。これは、担体と刺激応答性高分子の組合せが良かったためと考えられた。 From the above results, when the carrier C3 having an index A indicating the degree of dispersion of 0.5 and the stimulus-responsive polymer P4 having a partition coefficient CLogP of 0.19 are combined, the value of 10% DBC is as high as 32 mg / mL. was gotten. It was considered that this was because the combination of the carrier and the stimulus-responsive polymer was good.

<実施例4>
<担体C4(担体A群)上へ刺激応答性高分子P5を固定化した吸着材の調製>
THF/水混合溶液(THF:水=1:1(体積比))を溶媒として用い、刺激応答性高分子P5の1質量%溶液を調製した。この刺激応答性高分子P5の溶液と、カルボキシル基を表面に有する平均粒子径100μmのメタクリレート担体(東ソー社製、Toyoperal AF−Carboxy 650M)と、DMT−MM(10当量)とから得られた懸濁液を室温で一晩振盪させた。その後、THF/水混合溶媒で洗浄し、刺激応答性高分子P5が担体C4に固定化された実施例4に係る吸着材を得た。
<Example 4>
<Preparation of an adsorbent in which a stimulus-responsive polymer P5 is immobilized on carrier C4 (carrier A group)>
A 1% by mass solution of the stimulus-responsive polymer P5 was prepared using a THF / water mixed solution (THF: water = 1: 1 (volume ratio)) as a solvent. A suspension obtained from a solution of this stimulus-responsive polymer P5, a methacrylate carrier having a carboxyl group on the surface and an average particle size of 100 μm (Tosoh, Toyoperal AF-Carboxy 650M), and DMT-MM (10 equivalents). The turbid solution was shaken overnight at room temperature. Then, it was washed with a mixed solvent of THF / water to obtain the adsorbent according to Example 4 in which the stimulus-responsive polymer P5 was immobilized on the carrier C4.

<実施例4に係る吸着材の抗体吸着能評価>
実施例4に係る吸着材の吸着部位の抗体吸着能を評価するため、実施例1に係る吸着材と同様の手順で同様の実験を行った。その結果を後記表3及び図4に示す。
表3及び図4に示すように、実施例4に係る吸着材1mLに対し、23mgの抗体が吸着することが確認された。
<Evaluation of antibody adsorption ability of adsorbent according to Example 4>
In order to evaluate the antibody adsorbing ability of the adsorbing site of the adsorbent according to Example 4, the same experiment was conducted in the same procedure as that of the adsorbent according to Example 1. The results are shown in Table 3 and FIG. 4 below.
As shown in Table 3 and FIG. 4, it was confirmed that 23 mg of the antibody was adsorbed on 1 mL of the adsorbent according to Example 4.

以上の結果から、分散度を示す指標Aが1.0の担体C4と、分配係数CLogPが−0.46の刺激応答性高分子P5とを組み合わせたとき、10%DBCは23mg/mLであり、市販品として流通する吸着材の最低限の機能20mg/mL以上が得られることが明らかとなった。これは、担体と刺激応答性高分子の組合せが良かったためと考えられた。 From the above results, when the carrier C4 having an index A indicating the degree of dispersion of 1.0 and the stimulus-responsive polymer P5 having a partition coefficient CLogP of −0.46 are combined, the 10% DBC is 23 mg / mL. , It was clarified that the minimum function of 20 mg / mL or more of the adsorbent distributed as a commercial product can be obtained. It was considered that this was because the combination of the carrier and the stimulus-responsive polymer was good.

<実施例5>
<担体C5(担体B群)上へ刺激応答性高分子P1を固定化した吸着材の調製>
THF/水混合溶液(THF:水=5:1(体積比))を溶媒として用い、刺激応答性高分子P1の1質量%溶液を調製した。この刺激応答性高分子P1の溶液と、カルボキシル基を表面に有する平均粒子径100μmのSepharose担体(GEヘルスケア社製、CM Sepharose 4 Fast Flow)と、DMT−MM(10当量)とから得られた懸濁液を室温で一晩振盪させた。その後、THF/水混合溶媒で洗浄し、刺激応答性高分子P1が担体C5に固定化された実施例5に係る吸着材を得た。
<Example 5>
<Preparation of an adsorbent in which a stimulus-responsive polymer P1 is immobilized on carrier C5 (carrier B group)>
A 1% by mass solution of the stimulus-responsive polymer P1 was prepared using a THF / water mixed solution (THF: water = 5: 1 (volume ratio)) as a solvent. Obtained from this stimulus-responsive polymer P1 solution, a Sepharose carrier having a carboxyl group on the surface and an average particle size of 100 μm (CM Sepharose 4 Fast Flow manufactured by GE Healthcare), and DMT-MM (10 equivalents). The suspension was shaken overnight at room temperature. Then, it was washed with a mixed solvent of THF / water to obtain the adsorbent according to Example 5 in which the stimulus-responsive polymer P1 was immobilized on the carrier C5.

<実施例5に係る吸着材の抗体吸着能評価>
実施例5に係る吸着材の吸着部位の抗体吸着能を評価するため、実施例1に係る吸着材と同様の手順で同様の実験を行った。その結果を後記表3及び図4に示す。
表3及び図4に示すように、実施例5に係る吸着材1mLに対し、38mgの抗体が吸着することが確認された。
<Evaluation of antibody adsorption ability of adsorbent according to Example 5>
In order to evaluate the antibody adsorbing ability of the adsorbent site of the adsorbent according to Example 5, the same experiment was conducted in the same procedure as that of the adsorbent according to Example 1. The results are shown in Table 3 and FIG. 4 below.
As shown in Table 3 and FIG. 4, it was confirmed that 38 mg of the antibody was adsorbed on 1 mL of the adsorbent according to Example 5.

以上の結果から、分散度を示す指標Aが−2.5の担体C5と、分配係数CLogPが1.3の刺激応答性高分子P1とを組み合わせたとき、10%DBCは38mg/mLと高効率に抗体を吸着することが確認された。これは、担体と刺激応答性高分子の組合せが良かったためと考えられた。 From the above results, when the carrier C5 having an index A indicating the degree of dispersion of -2.5 and the stimulus-responsive polymer P1 having a partition coefficient CLogP of 1.3 are combined, the 10% DBC is as high as 38 mg / mL. It was confirmed that the antibody was adsorbed efficiently. It was considered that this was because the combination of the carrier and the stimulus-responsive polymer was good.

<実施例6>
<担体C6(担体B群)上へ刺激応答性高分子P3を固定化した吸着材の調製>
THF/水混合溶液(THF:水=4:1(体積比))を溶媒として用い、刺激応答性高分子P3の1質量%溶液を調製した。この刺激応答性高分子P3の溶液と、カルボキシル基を表面に有する平均粒子径100μmのシリカ担体(AGCエスアイテック社製、M.S.GEL、Dグレード)と、DMT−MM(10当量)とから得られた懸濁液を室温で一晩振盪させた。その後、THF/水混合溶媒で洗浄し、刺激応答性高分子P3が担体C6に固定化された実施例6に係る吸着材を得た。
<Example 6>
<Preparation of an adsorbent in which a stimulus-responsive polymer P3 is immobilized on carrier C6 (carrier B group)>
A 1% by mass solution of the stimulus-responsive polymer P3 was prepared using a THF / water mixed solution (THF: water = 4: 1 (volume ratio)) as a solvent. A solution of this stimulus-responsive polymer P3, a silica carrier having a carboxyl group on the surface and an average particle size of 100 μm (made by AGC Si-Tech, MS GEL, D grade), and DMT-MM (10 equivalents). The suspension obtained from was shaken overnight at room temperature. Then, it was washed with a mixed solvent of THF / water to obtain the adsorbent according to Example 6 in which the stimulus-responsive polymer P3 was immobilized on the carrier C6.

<実施例6に係る吸着材の抗体吸着能評価>
実施例6に係る吸着材の吸着部位の抗体吸着能を評価するため、実施例1に係る吸着材と同様の手順で同様の実験を行った。その結果を後記表3及び図4に示す。
表3及び図4に示すように、実施例6に係る吸着材1mLに対し、37mgの抗体が吸着することが確認された。
<Evaluation of antibody adsorption ability of adsorbent according to Example 6>
In order to evaluate the antibody adsorbing ability of the adsorbent site of the adsorbent according to Example 6, the same experiment was conducted in the same procedure as that of the adsorbent according to Example 1. The results are shown in Table 3 and FIG. 4 below.
As shown in Table 3 and FIG. 4, it was confirmed that 37 mg of the antibody was adsorbed on 1 mL of the adsorbent according to Example 6.

以上の結果から、分散度を示す指標Aが−3.0の担体C6と、分配係数CLogPが0.62の刺激応答性高分子P3とを組み合わせたとき、10%DBCは37mg/mLと高効率に抗体を吸着することが確認された。これは、担体と刺激応答性高分子の組合せが良かったためと考えられた。 From the above results, when the carrier C6 having an index A indicating the degree of dispersion of -3.0 and the stimulus-responsive polymer P3 having a partition coefficient CLogP of 0.62 are combined, the 10% DBC is as high as 37 mg / mL. It was confirmed that the antibody was adsorbed efficiently. It was considered that this was because the combination of the carrier and the stimulus-responsive polymer was good.

<実施例7>
<担体C7(担体B群)上へ刺激応答性高分子P1を固定化した吸着材の調製>
THF/水混合溶液(THF:水=5:1(体積比))を溶媒として用い、刺激応答性高分子P1の1質量%溶液を調製した。この刺激応答性高分子P1の溶液と、カルボキシル基を表面に有する平均粒子径50μmのシリカ担体(AGCエスアイテック社製、M.S.GEL、EP−DMグレード)と、DMT−MM(10当量)とから得られた懸濁液を室温で一晩振盪させた。その後、THF/水混合溶媒で洗浄し、刺激応答性高分子P1が担体C7に固定化された実施例7に係る吸着材を得た。
<Example 7>
<Preparation of an adsorbent in which a stimulus-responsive polymer P1 is immobilized on carrier C7 (carrier B group)>
A 1% by mass solution of the stimulus-responsive polymer P1 was prepared using a THF / water mixed solution (THF: water = 5: 1 (volume ratio)) as a solvent. A solution of this stimulus-responsive polymer P1, a silica carrier having a carboxyl group on the surface and an average particle size of 50 μm (manufactured by AGC Si-Tech, MSGEL, EP-DM grade), and DMT-MM (10 equivalents). ) And the suspension obtained from was shaken overnight at room temperature. Then, it was washed with a mixed solvent of THF / water to obtain the adsorbent according to Example 7 in which the stimulus-responsive polymer P1 was immobilized on the carrier C7.

<実施例7に係る吸着材の抗体吸着能評価>
実施例7に係る吸着材の吸着部位の抗体吸着能を評価するため、実施例1に係る吸着材と同様の手順で同様の実験を行った。その結果を後記表3及び図4に示す。
表3及び図4に示すように、実施例7に係る吸着材1mLに対し、48mgの抗体が吸着することが確認された。
<Evaluation of antibody adsorption ability of adsorbent according to Example 7>
In order to evaluate the antibody adsorbing ability of the adsorbent site of the adsorbent according to Example 7, the same experiment was conducted in the same procedure as that of the adsorbent according to Example 1. The results are shown in Table 3 and FIG. 4 below.
As shown in Table 3 and FIG. 4, it was confirmed that 48 mg of the antibody was adsorbed on 1 mL of the adsorbent according to Example 7.

以上の結果から、分散度を示す指標Aが−3.5の担体C7と、分配係数CLogPが1.3の刺激応答性高分子P1とを組み合わせたとき、10%DBCは48mg/mLと高効率に抗体を吸着することが確認された。これは、親水的かつ平均粒子径が小さい担体と、疎水的ではあるが、吸着部位として導入した低分子化合物(MBTA)の導入量が多い刺激応答性高分子との組合せが良かったためと考えられた。 From the above results, when the carrier C7 having an index A indicating the degree of dispersion of -3.5 and the stimulus-responsive polymer P1 having a partition coefficient CLogP of 1.3 are combined, the 10% DBC is as high as 48 mg / mL. It was confirmed that the antibody was adsorbed efficiently. It is considered that this is because the combination of the carrier which is hydrophilic and has a small average particle size and the stimulus-responsive polymer which is hydrophobic but introduces a large amount of the small molecule compound (MBTA) introduced as an adsorption site is good. rice field.

<実施例8>
<担体C8(担体B群)上へ刺激応答性高分子P2を固定化した吸着材の調製>
THF/水混合溶液(THF:水=5:1(体積比))を溶媒として用い、刺激応答性高分子P2の1質量%溶液を調製した。この刺激応答性高分子P2の溶液と、カルボキシル基を表面に有する平均粒子径3μmの磁性担体(タカラバイオ社製、Magnospere MS300/Carboxyl)と、DMT−MM(10当量)とから得られた懸濁液を室温で一晩振盪させた。その後、THF/水混合溶媒で洗浄し、刺激応答性高分子P2が担体C8に固定化された実施例8に係る吸着材を得た。
<Example 8>
<Preparation of an adsorbent in which a stimulus-responsive polymer P2 is immobilized on carrier C8 (carrier B group)>
A 1% by mass solution of the stimulus-responsive polymer P2 was prepared using a THF / water mixed solution (THF: water = 5: 1 (volume ratio)) as a solvent. A suspension obtained from a solution of this stimulus-responsive polymer P2, a magnetic carrier having a carboxyl group on the surface and an average particle size of 3 μm (Magnospere MS300 / Carboxyl manufactured by Takara Bio Inc.), and DMT-MM (10 equivalents). The turbid solution was shaken overnight at room temperature. Then, it was washed with a mixed solvent of THF / water to obtain the adsorbent according to Example 8 in which the stimulus-responsive polymer P2 was immobilized on the carrier C8.

<実施例8に係る吸着材の抗体吸着能評価>
実施例8に係る吸着材の吸着部位の抗体吸着能を評価するため、実施例1に係る吸着材と同様の手順で同様の実験を行った。その結果を後記表3及び図4に示す。
表3及び図4に示すように、実施例8に係る吸着材1mLに対し、27mgの抗体が吸着することが確認された。
<Evaluation of antibody adsorption ability of adsorbent according to Example 8>
In order to evaluate the antibody adsorbing ability of the adsorbing site of the adsorbent according to Example 8, the same experiment was carried out in the same procedure as that of the adsorbent according to Example 1. The results are shown in Table 3 and FIG. 4 below.
As shown in Table 3 and FIG. 4, it was confirmed that 27 mg of the antibody was adsorbed on 1 mL of the adsorbent according to Example 8.

以上の結果から、分散度を示す指標Aが−1.0の担体C8と、分配係数CLogPが1.1の刺激応答性高分子P2とを組み合わせたとき、10%DBCは27mg/mLであり、市販製品と同等以上に抗体を吸着できることが確認された。 From the above results, when the carrier C8 having an index A indicating the degree of dispersion of -1.0 and the stimulus-responsive polymer P2 having a partition coefficient CLogP of 1.1 are combined, the 10% DBC is 27 mg / mL. , It was confirmed that the antibody can be adsorbed at the same level as the commercially available product.

<実施例9>
<担体C5(担体B群)上へ刺激応答性高分子P2を固定化した吸着材の調製>
THF/水混合溶液(THF:水=5:1(体積比))を溶媒として用い、刺激応答性高分子P2の1質量%溶液を調製した。この刺激応答性高分子P2の溶液と、カルボキシル基を表面に有する平均粒子径100μmのSepharose担体(GEヘルスケア社製、CM Sepharose 4 Fast Flow)と、DMT−MM(10当量)とから得られた懸濁液を室温で一晩振盪させた。その後、THF/水混合溶媒で洗浄し、刺激応答性高分子P2が担体C5に固定化された実施例9に係る吸着材を得た。
<Example 9>
<Preparation of an adsorbent in which a stimulus-responsive polymer P2 is immobilized on carrier C5 (carrier B group)>
A 1% by mass solution of the stimulus-responsive polymer P2 was prepared using a THF / water mixed solution (THF: water = 5: 1 (volume ratio)) as a solvent. Obtained from this stimulus-responsive polymer P2 solution, a Sepharose carrier having a carboxyl group on the surface and an average particle size of 100 μm (CM Sepharose 4 Fast Flow manufactured by GE Healthcare), and DMT-MM (10 equivalents). The suspension was shaken overnight at room temperature. Then, it was washed with a mixed solvent of THF / water to obtain the adsorbent according to Example 9 in which the stimulus-responsive polymer P2 was immobilized on the carrier C5.

<実施例9に係る吸着材の抗体吸着能評価>
実施例9に係る吸着材の吸着部位の抗体吸着能を評価するため、実施例1に係る吸着材と同様の手順で同様の実験を行った。その結果を後記表3及び図4に示す。
表3及び図4に示すように、実施例9に係る吸着材1mLに対し、26mgの抗体が吸着することが確認された。
<Evaluation of antibody adsorption ability of adsorbent according to Example 9>
In order to evaluate the antibody adsorbing ability of the adsorbing site of the adsorbent according to Example 9, the same experiment was conducted in the same procedure as that of the adsorbent according to Example 1. The results are shown in Table 3 and FIG. 4 below.
As shown in Table 3 and FIG. 4, it was confirmed that 26 mg of the antibody was adsorbed on 1 mL of the adsorbent according to Example 9.

以上の結果から、分散度を示す指標Aが−2.5の担体C5と、分配係数CLogPが1.1の刺激応答性高分子P2とを組み合わせたとき、10%DBCは26mg/mLであり、市販品と同等程度の抗体吸着能が得られることが確認された。 From the above results, when the carrier C5 having an index A indicating the degree of dispersion of -2.5 and the stimulus-responsive polymer P2 having a partition coefficient CLogP of 1.1 are combined, the 10% DBC is 26 mg / mL. It was confirmed that an antibody adsorption capacity equivalent to that of a commercially available product can be obtained.

なお、実施例9に係る吸着材と実施例5に係る吸着材とを比較すると、これらは担体及び刺激応答性高分子の組成が近いにも関わらず、10%DBCは実施例5に係る吸着材の方が優れていた。このことから、担体に対してより最適な分配係数CLogPを有する刺激応答性高分子を固定化すると大幅に10%DBCを向上できると考えられた。 Comparing the adsorbent according to Example 9 with the adsorbent according to Example 5, 10% DBC adsorbs according to Example 5 even though the compositions of the carrier and the stimulus-responsive polymer are similar. The material was better. From this, it was considered that immobilization of a stimulus-responsive polymer having a more optimal partition coefficient CLogP with respect to the carrier could significantly improve DBC by 10%.

<比較例1>
<担体C3(担体A群)上へ刺激応答性高分子P6を固定化した吸着材の調製>
THF/水混合溶液(THF:水=5:1(体積比))を溶媒として用い、刺激応答性高分子P6の1質量%溶液を調製した。この刺激応答性高分子P6の溶液と、カルボキシル基を表面に有する平均粒子径30μmのアクリル担体(Soken社製、MXシリーズ)と、DMT−MM(10当量)とから得られた懸濁液を室温で一晩振盪させた。その後、THF/水混合溶媒で洗浄し、刺激応答性高分子P6が担体C3に固定化された比較例1に係る吸着材を得た。
<Comparative example 1>
<Preparation of an adsorbent in which a stimulus-responsive polymer P6 is immobilized on carrier C3 (carrier A group)>
A 1% by mass solution of the stimulus-responsive polymer P6 was prepared using a THF / water mixed solution (THF: water = 5: 1 (volume ratio)) as a solvent. A suspension obtained from a solution of this stimulus-responsive polymer P6, an acrylic carrier having a carboxyl group on the surface and an average particle size of 30 μm (MX series manufactured by Soken), and DMT-MM (10 equivalents). It was shaken overnight at room temperature. Then, it was washed with a mixed solvent of THF / water to obtain the adsorbent according to Comparative Example 1 in which the stimulus-responsive polymer P6 was immobilized on the carrier C3.

<比較例1に係る吸着材の抗体吸着能評価>
比較例1に係る吸着材の吸着部位の抗体吸着能を評価するため、実施例1に係る吸着材と同様の手順で同様の実験を行った。その結果を後記表3及び図4に示す。
表3及び図4に示すように、比較例1に係る吸着材1mLに対し、4mgの抗体が吸着することが確認された。
<Evaluation of antibody adsorption ability of adsorbent according to Comparative Example 1>
In order to evaluate the antibody adsorbing ability of the adsorbent site of the adsorbent according to Comparative Example 1, the same experiment was conducted in the same procedure as that of the adsorbent according to Example 1. The results are shown in Table 3 and FIG. 4 below.
As shown in Table 3 and FIG. 4, it was confirmed that 4 mg of the antibody was adsorbed on 1 mL of the adsorbent according to Comparative Example 1.

以上の結果から、分散度を示す指標Aが0.5の担体C3と、分配係数CLogPが1.9の刺激応答性高分子P6を組み合わせたとき、10%DBCは4mg/mLと低い値を示した。この結果から、疎水性の担体と疎水的な刺激応答性高分子の組合せでは、担体と刺激応答性高分子との間の相互作用が高まり、十分量の抗体吸着能が得られなかったと考えられた。 From the above results, when the carrier C3 having an index A indicating the degree of dispersion of 0.5 and the stimulus-responsive polymer P6 having a partition coefficient CLogP of 1.9 are combined, the 10% DBC has a low value of 4 mg / mL. Indicated. From this result, it is considered that in the combination of the hydrophobic carrier and the hydrophobic stimulus-responsive polymer, the interaction between the carrier and the stimulus-responsive polymer was enhanced, and a sufficient amount of antibody adsorption ability could not be obtained. rice field.

<比較例2>
<担体C5(担体B群)上へ刺激応答性高分子P7を固定化した吸着材の調製>
THF/水混合溶液(THF:水=1:1(体積比))を溶媒として用い、刺激応答性高分子P7の1質量%溶液を調製した。この刺激応答性高分子P7の溶液と、カルボキシル基を表面に有する平均粒子径100μmのSepharose担体(GEヘルスケア社製、CM Sepharose 4 Fast Flow)と、DMT−MM(10当量)とから得られた懸濁液を室温で一晩振盪させた。その後、THF/水混合溶媒で洗浄し、刺激応答性高分子P7が担体C5に固定化された比較例2に係る吸着材を得た。
<Comparative example 2>
<Preparation of an adsorbent in which a stimulus-responsive polymer P7 is immobilized on carrier C5 (carrier B group)>
A 1% by mass solution of the stimulus-responsive polymer P7 was prepared using a THF / water mixed solution (THF: water = 1: 1 (volume ratio)) as a solvent. Obtained from this solution of the stimulus-responsive polymer P7, a Sepharose carrier having a carboxyl group on the surface and an average particle size of 100 μm (CM Sepharose 4 Fast Flow manufactured by GE Healthcare), and DMT-MM (10 equivalents). The suspension was shaken overnight at room temperature. Then, it was washed with a mixed solvent of THF / water to obtain the adsorbent according to Comparative Example 2 in which the stimulus-responsive polymer P7 was immobilized on the carrier C5.

<比較例2に係る吸着材の抗体吸着能評価>
比較例2に係る吸着材の吸着部位の抗体吸着能を評価するため、実施例1に係る吸着材と同様の手順で同様の実験を行った。その結果を後記表3及び図4に示す。
表3及び図4に示すように、比較例2に係る吸着材1mLに対し、6mgの抗体が吸着することが確認された。
<Evaluation of antibody adsorption ability of adsorbent according to Comparative Example 2>
In order to evaluate the antibody adsorbing ability of the adsorbing site of the adsorbent according to Comparative Example 2, the same experiment was conducted in the same procedure as that of the adsorbent according to Example 1. The results are shown in Table 3 and FIG. 4 below.
As shown in Table 3 and FIG. 4, it was confirmed that 6 mg of the antibody was adsorbed on 1 mL of the adsorbent according to Comparative Example 2.

以上の結果から、分散度を示す指標Aが−2.5の担体C5と、分配係数CLogPが−0.69の刺激応答性高分子P7とを組み合わせたとき、10%DBCは6mg/mLと低い値を示した。このことから、親水性の担体と、吸着部位として導入した低分子化合物(MBTA)の導入量が少なく、より親水的な刺激応答性高分子との組合せでは、十分量の抗体を吸着できないことが確認された。 From the above results, when the carrier C5 having an index A indicating the degree of dispersion of -2.5 and the stimulus-responsive polymer P7 having a partition coefficient CLogP of -0.69 are combined, the 10% DBC is 6 mg / mL. It showed a low value. From this, the amount of the small molecule compound (MBTA) introduced as the adsorption site is small, and the combination of the hydrophilic carrier and the more hydrophilic stimulus-responsive polymer cannot adsorb a sufficient amount of antibody. confirmed.

<比較例3>
<担体C9(担体A群)上へ刺激応答性高分子P3を固定化した吸着材の調製>
THF/水混合溶液(THF:水=4:1(体積比))を溶媒として用い、刺激応答性高分子P3の1質量%溶液を調製した。この刺激応答性高分子P3の溶液と、カルボキシル基を表面に有する平均粒子径45μmのメタクリレート担体(積水化成品社製、テクポリマー、MBX−40)と、DMT−MM(10当量)とから得られた懸濁液を室温で一晩振盪させた。その後、THF/水混合溶媒で洗浄し、刺激応答性高分子P3が担体C9に固定化された比較例3に係る吸着材を得た。
<Comparative example 3>
<Preparation of an adsorbent in which a stimulus-responsive polymer P3 is immobilized on carrier C9 (carrier A group)>
A 1% by mass solution of the stimulus-responsive polymer P3 was prepared using a THF / water mixed solution (THF: water = 4: 1 (volume ratio)) as a solvent. Obtained from this stimulus-responsive polymer P3 solution, a methacrylate carrier having a carboxyl group on the surface and an average particle size of 45 μm (Techpolymer, MBX-40, manufactured by Sekisui Kasei Co., Ltd.), and DMT-MM (10 equivalents). The suspension was shaken overnight at room temperature. Then, it was washed with a mixed solvent of THF / water to obtain the adsorbent according to Comparative Example 3 in which the stimulus-responsive polymer P3 was immobilized on the carrier C9.

<比較例3に係る吸着材の抗体吸着能評価>
比較例3に係る吸着材の吸着部位の抗体吸着能を評価するため、実施例1に係る吸着材と同様の手順で同様の実験を行った。その結果を後記表3及び図4に示す。
表3及び図4に示すように、比較例3に係る吸着材1mLに対し、15mgの抗体が吸着することが確認された。
<Evaluation of antibody adsorption ability of adsorbent according to Comparative Example 3>
In order to evaluate the antibody adsorption ability of the adsorbent site of the adsorbent according to Comparative Example 3, the same experiment was conducted in the same procedure as that of the adsorbent according to Example 1. The results are shown in Table 3 and FIG. 4 below.
As shown in Table 3 and FIG. 4, it was confirmed that 15 mg of the antibody was adsorbed on 1 mL of the adsorbent according to Comparative Example 3.

以上の結果から、分散度を示す指標Aが1.5の担体C9と、分配係数CLogPが0.62の刺激応答性高分子P3とを組み合わせたとき、10%DBCは15mg/mLであり、市販品の基準である20mg/mLと比較して僅かに劣った。このことから、吸着能が出ることが確認されている刺激応答性高分子であっても、指標Aが1.5以上であるような疎水性の担体との組み合わせ次第では、抗体の吸着能が僅かに低減することが判明した。比較例3に係る吸着材と実施例4に係る吸着材とを比較して、吸着材について、抗体の高効率吸着をかなえる担体の指標Aは1.0以下とするのがよいと考えられた。 From the above results, when the carrier C9 having an index A indicating the degree of dispersion of 1.5 and the stimulus-responsive polymer P3 having a partition coefficient CLogP of 0.62 are combined, the 10% DBC is 15 mg / mL. It was slightly inferior to the standard of 20 mg / mL for commercial products. From this, even if it is a stimulus-responsive polymer that has been confirmed to have adsorptive ability, the adsorptive ability of the antibody may be increased depending on the combination with a hydrophobic carrier having an index A of 1.5 or more. It was found to be slightly reduced. Comparing the adsorbent according to Comparative Example 3 with the adsorbent according to Example 4, it was considered that the index A of the carrier capable of achieving high-efficiency adsorption of the antibody should be 1.0 or less for the adsorbent. ..

Figure 0006927259
Figure 0006927259

以上の結果から、従来用いるのが困難であった疎水性の担体A群の担体を用いた場合であっても、分配係数CLogPが−0.46以上1.3以下である刺激応答性高分子を組み合わせることで10%DBCを高められることが分かった。また、親水性の担体B群に属する担体を用いた場合は、分配係数CLogPが−0.46以上1.3以下である刺激応答性高分子を用いて吸着材を製造することで高DBCが得られることが分かった。すなわち、本発明によれば、担体の前記指標Aが1.0以下であり、刺激応答性高分子の分配係数CLogPが−0.46以上1.3以下の範囲にある最適な組み合わせとすることによって、吸着部位として低分子化合物を用いることができるとともに、従来よりも多くの種類の担体を用いることができ、かつ、標的物質の吸着容量が高い吸着材とこれを用いたカラム及び精製装置とを提供できることが分かった。 From the above results, even when a carrier of the hydrophobic carrier group A, which has been difficult to use in the past, is used, a stimulus-responsive polymer having a partition coefficient CLogP of −0.46 or more and 1.3 or less. It was found that the DBC can be increased by 10% by combining the above. When a carrier belonging to the hydrophilic carrier B group is used, a high DBC can be obtained by producing an adsorbent using a stimulus-responsive polymer having a partition coefficient CLogP of −0.46 or more and 1.3 or less. It turned out to be obtained. That is, according to the present invention, the optimum combination is such that the index A of the carrier is 1.0 or less and the partition coefficient CRogP of the stimulus-responsive polymer is in the range of −0.46 or more and 1.3 or less. Therefore, a low-molecular-weight compound can be used as an adsorption site, more types of carriers can be used than before, and an adsorbent having a high adsorption capacity of a target substance, and a column and a purification device using the adsorbent. Turned out to be able to provide.

このことから、本発明では、医薬品や分析試薬向けの抗体を生産する抗体生産性が優れる吸着材とこれを用いたカラム及び精製装置とを提供できる。そして、本発明によれば、抗体の吸着効率向上をかなえる低分子化合物を用いた吸着材による抗体の精製を可能にする。従って、本発明によれば、抗体医薬品及び分析試薬等の低コスト製造や生産性向上を実現できる。そのため、本発明によれば、従来治療が困難であったリュウマチや癌治療等に用いる治療用抗体はもちろん、分析、試験で用いられる生化学試薬や臨床検査試薬中の抗体をも含めて高効率に生産、提供が可能となるため、医療技術の進歩に大きく貢献できる。 From this, it is possible to provide an adsorbent having excellent antibody productivity for producing an antibody for a pharmaceutical product or an analytical reagent, and a column and a purification apparatus using the same. Then, according to the present invention, it is possible to purify an antibody with an adsorbent using a small molecule compound that can improve the adsorption efficiency of the antibody. Therefore, according to the present invention, it is possible to realize low-cost production and productivity improvement of antibody drugs, analytical reagents and the like. Therefore, according to the present invention, not only therapeutic antibodies used for rheumatism and cancer treatment, which have been difficult to treat in the past, but also antibodies in biochemical reagents and clinical test reagents used in analysis and testing are included with high efficiency. Since it can be produced and provided, it can greatly contribute to the progress of medical technology.

以上、本発明に係る吸着材、カラム、精製装置及び吸着材の製造方法について実施形態及び実施例により詳細に説明したが、本発明の主旨はこれに限定されるものではなく、様々な変形例が含まれる。例えば、前記した実施形態は本発明を分かり易く説明するために詳細に説明したものであり、必ずしも説明した全ての構成を備えるものに限定されるものではない。また、ある実施形態の構成の一部を他の実施形態の構成に置き換えることが可能であり、また、ある実施形態の構成に他の実施形態の構成を加えることも可能である。また、各実施形態の構成の一部について、他の構成の追加・削除・置換をすることが可能である。 Although the adsorbent, the column, the purification apparatus, and the method for producing the adsorbent according to the present invention have been described in detail with reference to the embodiments and examples, the gist of the present invention is not limited to this, and various modifications are made. Is included. For example, the above-described embodiment has been described in detail in order to explain the present invention in an easy-to-understand manner, and is not necessarily limited to the one including all the described configurations. Further, it is possible to replace a part of the configuration of one embodiment with the configuration of another embodiment, and it is also possible to add the configuration of another embodiment to the configuration of one embodiment. Further, it is possible to add / delete / replace other configurations with respect to a part of the configurations of each embodiment.

1 吸着材
2 担体
3 吸着部位
4 刺激応答性高分子
5 高分子鎖
20 カラム
30 精製装置
O 標的物質
R 官能基
1 Adsorbent 2 Carrier 3 Adsorption site 4 Stimulus-responsive polymer 5 Polymer chain 20 Column 30 Purifier O Target substance R Functional group

Claims (7)

担体と、
標的物質を吸着する吸着部位及び前記吸着部位が導入されるアミノ基を含むとともに、前記担体に固定化された刺激応答性高分子と、
を含む吸着材であり、
前記担体は、誘電率の異なるオクタノール及びエタノールに分散させた際、それぞれの溶媒に対する前記担体の分散性を示す評価値から算出される指標Aが0以上1.0以下であり
記刺激応答性高分子は、分配係数CLogPが−0.46以上1.3以下であり、
前記指標Aは、前記オクタノール及び前記エタノールのそれぞれの溶媒に前記担体を分散させた分散液をシャーレに展開し、室温で10分静置した後、光学顕微鏡で撮像し得られた画像中の凝集体部分を黒色に、その他を白色に処理する二値化処理を行い、前記黒色で得られた凝集体部分の長さを1つの前記担体の直径で割った値をφとし、当該φの値に従って、評価値5:φ=0.2μm以上8.3μm未満、評価値4:φ=8.3μm以上17μm未満、評価値3:φ=17μm以上27μm未満、評価値2:φ=27μm以上40μm未満、評価値1:φ=40μm以上と評価し、これを1つのサンプルにつき5箇所の前記画像から得られた値の平均値を採用したものであり、さらに、これを1つのサンプルに対して2回繰り返して求めた平均値であって、前記オクタノールに分散させたときの評価値から、前記エタノールに分散させたときの評価値を差し引いた値を指標値とするものであり、
前記担体は、合成樹脂で形成されており、
前記吸着部位は、ベンゾチアゾール−2−酢酸、4−メルカプトベンゾチアゾール−2−酢酸エチル、5−メルカプトベンゾチアゾール−2−酢酸エチル、2−メルカプトチアゾール、3−(ベンゾチアゾール−2−イルチオ)プロパン−1−スルホン酸ナトリウム、2−メルカプト−6−ニトロベンゾチアゾール、3−(2−ベンゾチアゾリルチオ)プロピオン酸、2−メルカプト−1,3,4−チアジアゾール、N−メチル−2−メルカプトイミダゾール、ピリジルチオ酢酸、2−ベンゾチアゾリルチオ酢酸のうちから選択される少なくとも1種が、前記アミノ基にアミド結合したものである
ことを特徴とする吸着材。
With the carrier
A stimulus-responsive polymer that contains an adsorption site that adsorbs a target substance and an amino group into which the adsorption site is introduced and is immobilized on the carrier.
Is an adsorbent containing
When the carrier is dispersed in octanol and ethanol having different dielectric constants, the index A calculated from the evaluation value indicating the dispersibility of the carrier in each solvent is 0 or more and 1.0 or less .
Before SL stimuli-responsive polymer is partition coefficient CLogP is Ri der -0.46 to 1.3,
For the index A, a dispersion liquid in which the carrier is dispersed in each solvent of the octanol and the ethanol is developed on a chalet, allowed to stand at room temperature for 10 minutes, and then coagulated in an image obtained by imaging with an optical microscope. A binarization process is performed in which the aggregated portion is treated to black and the others are treated to white, and the value obtained by dividing the length of the aggregate portion obtained in black by the diameter of one carrier is defined as φ, and the value of φ is defined as φ. According to, evaluation value 5: φ = 0.2 μm or more and less than 8.3 μm, evaluation value 4: φ = 8.3 μm or more and less than 17 μm, evaluation value 3: φ = 17 μm or more and less than 27 μm, evaluation value 2: φ = 27 μm or more and 40 μm Less than, evaluation value 1: φ = 40 μm or more was evaluated, and the average value of the values obtained from the above images at five locations per sample was adopted, and this was further applied to one sample. It is an average value obtained by repeating it twice, and the value obtained by subtracting the evaluation value when dispersed in ethanol from the evaluation value when dispersed in octanol is used as an index value.
The carrier is made of a synthetic resin and
The adsorption sites are benzothiazole-2-acetic acid, 4-mercaptobenzothiazole-2-ethyl acetate, 5-mercaptobenzothiazole-2-ethylacetate, 2-mercaptothiazole, 3- (benzothiazole-2-ylthio) propane. Sodium -1-sulfonic acid, 2-mercapto-6-nitrobenzothiazole, 3- (2-benzothiazolylthio) propionic acid, 2-mercapto-1,3,4-thiazylazole, N-methyl-2-mercaptoimidazole , Pyridylthioacetic acid, 2-benzothiazolylthioacetic acid, an adsorbent characterized in that at least one selected is amide-bonded to the amino group.
請求項1に記載の吸着材において、
前記担体が、ポリメタクリレート、ポリスチレン、ポリアクリルアミド、アクリルの群から選択される一種以上であることを特徴とする吸着材。
In the adsorbent according to claim 1,
Wherein said carrier, Po Li methacrylate, polystyrene, polyacrylamide, adsorbent, characterized in that at least one member selected from the group of acrylic Le.
請求項1に記載の吸着材において、
前記刺激応答性高分子が、前記吸着部位を複数個有するとともにアミノ基を複数個有することを特徴とする吸着材。
In the adsorbent according to claim 1,
An adsorbent, wherein the stimulus-responsive polymer has a plurality of the adsorption sites and a plurality of amino groups.
請求項1に記載の吸着材において、
前記担体の平均粒子径が3μm以上100μm以下であることを特徴とする吸着材。
In the adsorbent according to claim 1,
An adsorbent having an average particle size of 3 μm or more and 100 μm or less of the carrier.
請求項1から請求項のいずれか1項に記載の吸着材が充填されていることを特徴とするカラム。 A column characterized in that the adsorbent according to any one of claims 1 to 4 is filled. 請求項1から請求項のいずれか1項に記載の吸着材が充填されたカラムを備えていることを特徴とする精製装置。 A purification apparatus comprising a column filled with the adsorbent according to any one of claims 1 to 4. 請求項1から請求項のいずれか1項に記載の吸着材を製造する製造方法であり、
誘電率の異なるオクタノール及びエタノールに分散させた際、それぞれの溶媒に対する分散性を示す評価値から算出される指標Aが0以上1.0以下である担体に、分配係数CLogPが−0.46以上1.3以下である刺激応答性高分子を固定させるものであり、
前記刺激応答性高分子は、標的物質を吸着する吸着部位及び前記吸着部位が導入されるアミノ基を含むとともに、前記担体に固定化されており、
前記指標Aは、前記オクタノール及び前記エタノールのそれぞれの溶媒に前記担体を分散させた分散液をシャーレに展開し、室温で10分静置した後、光学顕微鏡で撮像し得られた画像中の凝集体部分を黒色に、その他を白色に処理する二値化処理を行い、前記黒色で得られた凝集体部分の長さを1つの前記担体の直径で割った値をφとし、当該φの値に従って、評価値5:φ=0.2μm以上8.3μm未満、評価値4:φ=8.3μm以上17μm未満、評価値3:φ=17μm以上27μm未満、評価値2:φ=27μm以上40μm未満、評価値1:φ=40μm以上と評価し、これを1つのサンプルにつき5箇所の前記画像から得られた値の平均値を採用したものであり、さらに、これを1つのサンプルに対して2回繰り返して求めた平均値であって、前記オクタノールに分散させたときの評価値から、前記エタノールに分散させたときの評価値を差し引いた値を指標値とするものであり、
前記担体は、合成樹脂で形成されており、
前記吸着部位は、ベンゾチアゾール−2−酢酸、4−メルカプトベンゾチアゾール−2−酢酸エチル、5−メルカプトベンゾチアゾール−2−酢酸エチル、2−メルカプトチアゾール、3−(ベンゾチアゾール−2−イルチオ)プロパン−1−スルホン酸ナトリウム、2−メルカプト−6−ニトロベンゾチアゾール、3−(2−ベンゾチアゾリルチオ)プロピオン酸、2−メルカプト−1,3,4−チアジアゾール、N−メチル−2−メルカプトイミダゾール、ピリジルチオ酢酸、2−ベンゾチアゾリルチオ酢酸のうちから選択される少なくとも1種が、前記アミノ基にアミド結合したものである
ことを特徴とする吸着材の製造方法。
A manufacturing method for manufacturing the adsorbent according to any one of claims 1 to 4.
When dispersed in octanol and ethanol having different dielectric constants , a carrier having an index A of 0 or more and 1.0 or less calculated from an evaluation value indicating dispersibility in each solvent has a partition coefficient of -0.46 or more. It fixes a stimulus-responsive polymer that is 1.3 or less .
The stimulus-responsive polymer contains an adsorption site for adsorbing a target substance and an amino group into which the adsorption site is introduced, and is immobilized on the carrier.
For the index A, a dispersion liquid in which the carrier is dispersed in each solvent of the octanol and the ethanol is developed on a chalet, allowed to stand at room temperature for 10 minutes, and then coagulated in an image obtained by imaging with an optical microscope. A binarization process is performed in which the aggregated portion is treated to black and the others are treated to white, and the value obtained by dividing the length of the aggregate portion obtained in black by the diameter of one carrier is defined as φ, and the value of φ is defined as φ. According to, evaluation value 5: φ = 0.2 μm or more and less than 8.3 μm, evaluation value 4: φ = 8.3 μm or more and less than 17 μm, evaluation value 3: φ = 17 μm or more and less than 27 μm, evaluation value 2: φ = 27 μm or more and 40 μm Less than, evaluation value 1: φ = 40 μm or more was evaluated, and the average value of the values obtained from the above images at five locations per sample was adopted, and this was further applied to one sample. It is an average value obtained by repeating it twice, and the value obtained by subtracting the evaluation value when dispersed in ethanol from the evaluation value when dispersed in octanol is used as an index value.
The carrier is made of a synthetic resin and
The adsorption sites are benzothiazole-2-acetic acid, 4-mercaptobenzothiazole-2-ethyl acetate, 5-mercaptobenzothiazole-2-ethylacetate, 2-mercaptothiazole, 3- (benzothiazole-2-ylthio) propane. Sodium -1-sulfonic acid, 2-mercapto-6-nitrobenzothiazole, 3- (2-benzothiazolylthio) propionic acid, 2-mercapto-1,3,4-thiazylazole, N-methyl-2-mercaptoimidazole , A method for producing an adsorbent , wherein at least one selected from pyridylthioacetic acid and 2-benzothiazolylthioacetic acid is amide-bonded to the amino group.
JP2019159875A 2019-09-02 2019-09-02 Adsorbents, columns, refiners and methods for manufacturing adsorbents Expired - Fee Related JP6927259B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019159875A JP6927259B2 (en) 2019-09-02 2019-09-02 Adsorbents, columns, refiners and methods for manufacturing adsorbents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2019159875A JP6927259B2 (en) 2019-09-02 2019-09-02 Adsorbents, columns, refiners and methods for manufacturing adsorbents

Publications (2)

Publication Number Publication Date
JP2021037459A JP2021037459A (en) 2021-03-11
JP6927259B2 true JP6927259B2 (en) 2021-08-25

Family

ID=74847958

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019159875A Expired - Fee Related JP6927259B2 (en) 2019-09-02 2019-09-02 Adsorbents, columns, refiners and methods for manufacturing adsorbents

Country Status (1)

Country Link
JP (1) JP6927259B2 (en)

Also Published As

Publication number Publication date
JP2021037459A (en) 2021-03-11

Similar Documents

Publication Publication Date Title
CN1925898B (en) Process for Purifying Antibodies
KR101150050B1 (en) A process for the purification of antibodies
JP2013514524A (en) Specific solvent for binding protein and peptide, and separation method using the same
CN102015094A (en) Chromatography medium
CN104768536B (en) Functionalized particulate support materials and methods of making and using the same
JP6340317B2 (en) Cation exchange chromatography carrier for antibody purification and method for separating antibody monomer and polymer produced in the manufacturing process of antibody drug
CN105597370A (en) separation matrix
Padwal et al. Seeking innovative affinity approaches: a performance comparison between magnetic nanoparticle agglomerates and chromatography resins for antibody recovery
WO2016143215A1 (en) Adsorbent, separation/purification device including same, and separation/purification method
Hao et al. Rapid and high-capacity loading of IgG monoclonal antibodies by polymer brush and peptides functionalized microspheres
CN105579463B (en) Mixed Mode Ligands
CN1972746B (en) Isolation matrix and purification method
CN100516086C (en) Method for purifying immunoglobulin
WO2007064281A1 (en) Hydrophobic interaction chromatography
JP6927259B2 (en) Adsorbents, columns, refiners and methods for manufacturing adsorbents
Bayramoglu et al. Adsorption and separation of immunoglobulins by novel affinity core–shell beads decorated with Protein L and l-histidine
US9044740B2 (en) Purification of immunoglobulins
JP6927247B2 (en) Antibody purification method
JP2020022941A (en) Adsorbent and method for purifying target substance using the same
JP2016050897A (en) Production method of carrier, carrier, chromatography column, and purification method of target substance
JP6064402B2 (en) Separation agent and method for separation of antibody monomer
Bawazir Molecularly imprinted polymers for the selective extraction of biological macromolecules from aqueous media

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20191108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20191108

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200318

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20210122

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210302

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210430

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210514

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210706

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210719

R151 Written notification of patent or utility model registration

Ref document number: 6927259

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

LAPS Cancellation because of no payment of annual fees